MOBILE VIEW  | 

AMMONIA

Classification   |    Detailed evidence-based information

Therapeutic Toxic Class

    A) Aqueous ammonia is a colorless liquid with a strong alkaline reaction (pH 11.6) and a penetrating pungent odor. When heated to decomposition, it emits toxic fumes of ammonia and oxides of nitrogen (Lewis, 2000; Sax & Lewis, 1989).
    B) Ammonia may be absorbed by inhalation, ingestion, and probably by dermal exposure at concentrations high enough to cause skin injury (Clayton & Clayton, 1993; EPA, 1985).

Specific Substances

    1) Ammonia
    2) Ammonia anhydrous
    3) Ammonia gas
    4) Ammoniac (French)
    5) Ammoniaca (Italian)
    6) Ammoniak (German)
    7) Ammonium sulphate (2:1)
    8) Amoniak (Polish)
    9) Anhydrous ammonia
    10) Spirit of Hartshorn
    11) CAS 7664-41-7
    12) NH3
    1.2.1) MOLECULAR FORMULA
    1) H3-N
    2) NH3

Available Forms Sources

    A) FORMS
    1) Ammonia exists as a colorless gas. It is shipped as a liquefied compressed gas (HSDB, 2005).
    2) Household ammonia is 5 to 10% aqueous solution. Solutions of up to 54% are also available commercially (HSDB, 2005).
    B) SOURCES
    1) COMMERCIAL
    a) A modified Haber-Bosch reduction process is primarily used to manufacture ammonia. The reacts atmospheric nitrogen and a hydrogen source (e.g., methane, ethylene, or naphtha) under high temperatures (400 to 6500 degrees C) and pressures (100 to 900 atm) in the presence of an iron catalyst (HSDB, 2005; ATSDR, 2004; Clayton & Clayton, 1993).
    b) Other methods of producing ammonia include the use of refinery off-gases, coke-oven gas, electrolytic hydrogen, and calcium cyanimide (Lewis, 1997).
    c) Solar energy has been used in experimental conditions to produce ammonia (Lewis, 1997).
    d) Decomposing animal excreta from commercial farming operations (e.g., slurry pits, poultry houses, cattle fedlots) can be a significant source of ammonia release (ATSDR, 2004).
    e) Gaseous ammonia (NH3) is the toxic air pollutant most frequently found in high concentrations in animal facilities. Excessive tearing and clear or purulent nasal discharge are common symptoms of NH3 - vapor toxicity. Even at levels less than 100 ppm the primary effect is as a chronic stressor, since it irritates the respiratory mucosa from the nose to the lungs (Kirk, 1986).
    2) NATURAL
    a) Ammonia is the most abundant alkaline gas in the atmosphere (ATSDR, 2004).
    b) Decay of organic material, such as plant matter and animal carcasses, and decomposition of manure generate atmospheric ammonia (ATSDR, 2004).
    c) Ammonia is a major waste product of protein catabolism. It is produced primarily by microbial degradation of endogenous urea and dietary amines within the intestinal tract (Kirk, 1986).
    d) Non protein nitrogen (NPN) is any source of nitrogen that is not present in a polypeptide (precipitable protein) form. NPN is converted by ruminal microorganisms to ammonia, which is then combined with the carbohydrate-derived keto acids to form amino acids, the basic building blocks for protein synthesis (Haliburton et al, 1989).
    e) NON PROTEIN NITROGEN: Urea is the major non-protein nitrogen (NPN) source in use today and is commonly incorporated into range blocks, range cubes, and molasses - NPN combinations. Other NPN sources include feed grade biuret, gelatinized starch urea product, diammonium phosphate, ammonium phosphate solution, ammoniated rice hulls, ammoniated cottonseed meal, ammonium sulfate and mono-ammonium phosphate (Beasley et al, 1989).
    3) The toxin most frequently incriminated in hepatic encephalopathy is ammonia, which is generated by urease-producing colonic bacteria. An acute hepatic failure, impaired hepatic extraction or metabolism of ammonia results in excessive accumulation of ammonia in the blood, brain, and CSF fluid. Many factors increase ammonia production in the gut, including high-protein diets, gastrointestinal hemorrhage, and constipation (Kirk, 1986).
    4) Ammonia can be discharged in metropolitan areas as a by-product of heating fuel combustion (e.g., coal, oil, natural gas) (HSDB, 2005; Verschueren, 2001).
    C) USES
    1) Ammonia is used as a refrigerant, a fertilizer, in explosives, as a cleaning and bleaching agent and is widely used as a household cleaner (HSDB, 2005; ACGIH, 1991; (ASTI, 1999); Lewis, 1997).
    2) In industry, ammonia is used for nitriding of steel; as a condensation catalyst for polymers; in synthetic fibers and resins; as a dyeing or neutralizing agent in the petroleum industry; as a latex preservative; in explosives; and in the manufacture of nitric acid, hydrazine hydrate, hydrogen cyanide, nitrocellulose, ureaformaldehyde, nitroparaffins, melamine ethylenediamine, sulfite cooking liquors and acrylonitrile (HSDB, 2005; ATSDR, 2004; ACGIH, 1991; Lewis, 1997).
    3) Ammonia solutions containing 10 to 35% ammonia are generally used in cleaning compounds and to make other chemicals (AAR, 1994).
    4) Less than 2% of ammonia is used for refrigeration and 80% is used for agriculture ((ASTI, 1999)).
    5) Anhydrous ammonia is used as a fertilizer, refrigerant, and in the manufacture of other chemicals (AAR, 2000).

Life Support

    A) This overview assumes that basic life support measures have been instituted.

Clinical Effects

    0.2.1) SUMMARY OF EXPOSURE
    A) USES: Ammonia is used as a refrigerant, a fertilizer, in explosives, and as a cleaning and bleaching agent, and is widely available for household use.
    B) TOXICOLOGY: Ammonia may cause liquefaction necrosis. It can saponify the fats in the cell membrane, destroying the cell and allowing deep penetration into mucosal tissue. In gastrointestinal tissue an initial inflammatory phase may be followed by tissue necrosis (sometimes resulting in perforation), then granulation and finally stricture formation.
    C) EPIDEMIOLOGY: Ammonia is widely available in household cleaners and in fertilizers; exposure is common. Serious effects are rare in the developed world (generally only seen in adults with deliberate ingestion), largely because household ammonia is typically available in low concentrations (5% to 10% aqueous solution). Serious effects are more common in developing countries.
    D) WITH POISONING/EXPOSURE
    1) MILD TO MODERATE ORAL TOXICITY: Patients with mild ingestions may only develop irritation or grade I (superficial hyperemia and edema) burns of the oropharynx, esophagus or stomach; acute or chronic complications are unlikely. Patients with moderate toxicity may develop grade II burns (superficial blisters, erosions and ulcerations) are at risk for subsequent stricture formation, particularly esophageal. Some patients (particularly young children) may develop upper airway edema.
    a) Ammonia ingestion may produce burns to the oropharynx, upper airway, esophagus and occasionally stomach. Spontaneous vomiting may occur. The absence of visible oral burns does NOT reliably exclude the presence of esophageal burns. The presence of stridor, vomiting, drooling, and abdominal pain are associated with serious esophageal injury in most cases.
    b) PREDICTIVE: The grade of mucosal injury at endoscopy is the strongest predictive factor for the occurrence of systemic and GI complications and mortality.
    2) SEVERE ORAL TOXICITY: May develop deep burns and necrosis of the gastrointestinal mucosa. Complications often include perforation (esophageal, gastric, rarely duodenal), fistula formation (tracheoesophageal, aortoesophageal), and gastrointestinal bleeding. Upper airway edema is common and often life threatening. Hypotension, tachycardia, tachypnea and, rarely, fever may develop. Stricture formation (esophageal, less often oral or gastric) is likely to develop long term. Esophageal carcinoma is another long term complication. Severe toxicity is generally limited to deliberate ingestions in adults in the US, because ammonia products available in the home are generally of low concentration.
    3) INHALATION EXPOSURE: Mild exposure may cause cough and bronchospasm. Severe inhalation may cause upper airway edema and burns, stridor, and rarely acute lung injury.
    4) OCULAR EXPOSURE: Ocular exposure can produce severe conjunctival irritation and chemosis, corneal epithelial defects, limbal ischemia, permanent visual loss and in severe cases perforation.
    5) DERMAL EXPOSURE: Mild exposure causes irritation and partial thickness burns. Prolonged exposure or high concentration products can cause full thickness burns.
    0.2.3) VITAL SIGNS
    A) WITH POISONING/EXPOSURE
    1) Increases in blood pressure and pulse rate may occur.
    0.2.20) REPRODUCTIVE
    A) At the time of this review, no data were available to assess the teratogenic potential of this agent.
    B) Decreased egg production has occurred in experimental animals. Ammonia crosses the ovine placental barrier.
    C) At the time of this review, no data were available to assess the potential effects of exposure to this agent during lactation.
    D) No information about possible male reproductive effects was found in available references at the time of this review.

Laboratory Monitoring

    A) Obtain a complete blood count in symptomatic patients following an ammonia ingestion.
    B) In patients with signs and symptoms suggesting severe burns, perforation, or bleeding (or adults with deliberate, high volume or high concentration ingestions), obtain renal function tests, serum electrolytes, INR, PTT, type and crossmatch for blood, and monitor urine output. Serum lactate and base deficit may also be useful in these patients.
    C) Monitor pulse oximetry or arterial blood gases in patients with signs and symptoms suggestive of upper airway edema or burns.
    D) Obtain an upright chest x-ray in patients with signs and symptoms suggesting severe burns, perforation, or bleeding (or adults with deliberate, high volume or high concentration ingestions) to evaluate for pneumomediastinum or free air under the diaphragm. The absence of these findings DOES NOT rule out the possibility of necrosis or perforation of the esophagus or stomach. Obtain a chest radiograph in patients with pulmonary signs or symptoms.
    E) Several weeks after ingestion, barium contrast radiographs of the upper GI tract are useful in patients who sustained grade II or III burns, to evaluate for strictures.

Treatment Overview

    0.4.2) ORAL/PARENTERAL EXPOSURE
    A) MANAGEMENT OF MILD TO MODERATE ORAL TOXICITY
    1) Perform early (within 12 hours) endoscopy in patients with stridor, drooling, vomiting, significant oral burns, difficulty swallowing or abdominal pain, and in all patients with deliberate ingestion. If burns are absent or grade I severity, patient may be discharged when able to tolerate liquids and soft foods by mouth. If mild grade II burns, admit for intravenous fluids, slowly advance diet as tolerated. Perform barium swallow or repeat endoscopy several weeks after ingestion (sooner if difficulty swallowing) to evaluate for stricture formation.
    B) SEVERE ORAL TOXICITY
    1) Resuscitate with 0.9% saline; blood products may be necessary. Early airway management in patients with upper airway edema or respiratory distress. Early (within 12 hours) gastrointestinal endoscopy to evaluate for burns. Early bronchoscopy in patients with respiratory distress or upper airway edema. Early surgical consultation for patients with severe grade II or grade III burns, large deliberate ingestions, or signs, symptoms or laboratory findings concerning for tissue necrosis or perforation.
    C) DILUTION
    1) Dilute with 4 to 8 ounces of water may be useful if it can be performed shortly after ingestion in patients who are able to swallow, with no vomiting or respiratory distress; then the patient should be NPO until assessed for the need for endoscopy. Neutralization, activated charcoal, and gastric lavage are all contraindicated.
    D) AIRWAY MANAGEMENT
    1) Aggressive airway management in patients with deliberate ingestions or any indication of upper airway injury.
    E) ENDOSCOPY
    1) Should be performed as soon as possible (preferably within 12 hours, not more than 24 hours) in any patient with deliberate ingestion, adults with any signs or symptoms attributable to inadvertent ingestion, and in children with stridor, vomiting, or drooling after inadvertent ingestion. Endoscopy should also be considered in children with dysphagia or refusal to swallow, significant oral burns, or abdominal pain after unintentional ingestion. Children and adults who are asymptomatic after inadvertent ingestion do not require endoscopy. The grade of mucosal injury at endoscopy is the strongest predictive factor for the occurrence of systemic and GI complications and mortality. The absence of visible oral burns does NOT reliably exclude the presence of esophageal burns.
    F) CORTICOSTEROIDS
    1) The use of corticosteroids to prevent stricture formation is controversial. Corticosteroids should not be used in patients with grade I or grade III injury, as there is no evidence that it is effective. Evidence for grade II burns is conflicting, and the risk of perforation and infection is increased with steroid use.
    G) STRICTURE
    1) A barium swallow or repeat endoscopy should be performed several weeks after ingestion in any patient with grade II or III burns or with difficulty swallowing to evaluate for stricture formation. Recurrent dilation may be required. Some authors advocate early stent placement in these patients to prevent stricture formation.
    H) SURGICAL MANAGEMENT
    1) Immediate surgical consultation should be obtained on any patient with grade III or severe grade II burns on endoscopy, significant abdominal pain, metabolic acidosis, hypotension, coagulopathy, or a history of a large ingestion. Early laparotomy can identify tissue necrosis and impending or unrecognized perforation, early resection and repair in these patients is associated with improved outcome.
    I) PATIENT DISPOSITION
    1) OBSERVATION CRITERIA: Patients with ammonia ingestion should be sent to a health care facility for evaluation. Patients who remain asymptomatic over 4 to 6 hours of observation, and those with endoscopic evaluation that demonstrates no burns or only minor grade I burns and who can tolerate oral intake can be discharged home.
    2) ADMISSION CRITERIA: Symptomatic patients, and those with endoscopically demonstrated grade II or higher burns should be admitted. Patients with respiratory distress, grade III burns, acidosis, hemodynamic instability, gastrointestinal bleeding, or large ingestions should be admitted to an intensive care setting.
    J) PITFALLS
    1) The absence of oral burns does NOT reliably exclude the possibility of significant esophageal burns.
    2) Patients may have severe tissue necrosis and impending perforation requiring early surgical intervention without having severe hypotension, rigid abdomen, or radiographic evidence of intraperitoneal air.
    3) Patients with any evidence of upper airway involvement require early airway management before airway edema progresses.
    4) The extent of eye injury (degree of corneal opacification and perilimbal whitening) may not be apparent for 48 to 72 hours after the burn. All patients with corrosive eye injury should be evaluated by an ophthalmologist.
    K) DIFFERENTIAL DIAGNOSIS
    1) Acid ingestion, gastrointestinal hemorrhage, or perforated viscus.
    0.4.3) INHALATION EXPOSURE
    A) DECONTAMINATION
    1) Administer oxygen as necessary. Monitor for respiratory distress.
    B) AIRWAY MANAGEMENT
    1) Manage airway aggressively in patients with significant respiratory distress, stridor or any evidence of upper airway edema. Monitor for hypoxia or respiratory distress.
    C) BRONCHOSPASM
    1) Treat with oxygen, inhaled beta agonists and consider systemic corticosteroids.
    0.4.4) EYE EXPOSURE
    A) DECONTAMINATION
    1) Exposed eyes should be irrigated with copious amounts of 0.9% saline for at least 30 minutes, until pH is neutral and the cul de sacs are free of particulate material.
    2) An eye examination should always be performed, including slit lamp examination. Ophthalmologic consultation should be obtained. Antibiotics and mydriatics may be indicated.
    0.4.5) DERMAL EXPOSURE
    A) OVERVIEW
    1) DECONTAMINATION
    a) Remove contaminated clothes and any particulate matter adherent to skin. Irrigate exposed skin with copious amounts of water for at least 15 minutes or longer, depending on concentration, amount and duration of exposure to the chemical. A physician may need to examine the area if irritation or pain persist.

Range Of Toxicity

    A) Serious burns less likely if pH <11.5. Injury greater with either large ingestion (usually deliberate) or high concentration ammonia (usually not household products which typically contain 5% to 10% ammonia).
    B) With highly concentrated liquids (27% to 30% industrial strength ammonia), esophageal burns may occur in up to 100% of patients, even after accidental ingestion.

Summary Of Exposure

    A) USES: Ammonia is used as a refrigerant, a fertilizer, in explosives, and as a cleaning and bleaching agent, and is widely available for household use.
    B) TOXICOLOGY: Ammonia may cause liquefaction necrosis. It can saponify the fats in the cell membrane, destroying the cell and allowing deep penetration into mucosal tissue. In gastrointestinal tissue an initial inflammatory phase may be followed by tissue necrosis (sometimes resulting in perforation), then granulation and finally stricture formation.
    C) EPIDEMIOLOGY: Ammonia is widely available in household cleaners and in fertilizers; exposure is common. Serious effects are rare in the developed world (generally only seen in adults with deliberate ingestion), largely because household ammonia is typically available in low concentrations (5% to 10% aqueous solution). Serious effects are more common in developing countries.
    D) WITH POISONING/EXPOSURE
    1) MILD TO MODERATE ORAL TOXICITY: Patients with mild ingestions may only develop irritation or grade I (superficial hyperemia and edema) burns of the oropharynx, esophagus or stomach; acute or chronic complications are unlikely. Patients with moderate toxicity may develop grade II burns (superficial blisters, erosions and ulcerations) are at risk for subsequent stricture formation, particularly esophageal. Some patients (particularly young children) may develop upper airway edema.
    a) Ammonia ingestion may produce burns to the oropharynx, upper airway, esophagus and occasionally stomach. Spontaneous vomiting may occur. The absence of visible oral burns does NOT reliably exclude the presence of esophageal burns. The presence of stridor, vomiting, drooling, and abdominal pain are associated with serious esophageal injury in most cases.
    b) PREDICTIVE: The grade of mucosal injury at endoscopy is the strongest predictive factor for the occurrence of systemic and GI complications and mortality.
    2) SEVERE ORAL TOXICITY: May develop deep burns and necrosis of the gastrointestinal mucosa. Complications often include perforation (esophageal, gastric, rarely duodenal), fistula formation (tracheoesophageal, aortoesophageal), and gastrointestinal bleeding. Upper airway edema is common and often life threatening. Hypotension, tachycardia, tachypnea and, rarely, fever may develop. Stricture formation (esophageal, less often oral or gastric) is likely to develop long term. Esophageal carcinoma is another long term complication. Severe toxicity is generally limited to deliberate ingestions in adults in the US, because ammonia products available in the home are generally of low concentration.
    3) INHALATION EXPOSURE: Mild exposure may cause cough and bronchospasm. Severe inhalation may cause upper airway edema and burns, stridor, and rarely acute lung injury.
    4) OCULAR EXPOSURE: Ocular exposure can produce severe conjunctival irritation and chemosis, corneal epithelial defects, limbal ischemia, permanent visual loss and in severe cases perforation.
    5) DERMAL EXPOSURE: Mild exposure causes irritation and partial thickness burns. Prolonged exposure or high concentration products can cause full thickness burns.

Vital Signs

    3.3.1) SUMMARY
    A) WITH POISONING/EXPOSURE
    1) Increases in blood pressure and pulse rate may occur.
    3.3.4) BLOOD PRESSURE
    A) WITH POISONING/EXPOSURE
    1) During controlled acute human exposures (approximately 500 ppm for 30 minutes), increases in blood pressure and pulse rate were noted (HSDB , 2001).
    3.3.5) PULSE
    A) WITH POISONING/EXPOSURE
    1) TACHYCARDIA: During controlled human exposures, at approximately 500 ppm for 30 minutes, increases in pulse rate were noted (HSDB , 2001).

Heent

    3.4.3) EYES
    A) WITH POISONING/EXPOSURE
    1) INITIAL INJURY: The initial findings in an ammonia-injured eye include conjunctival hyperemia, lacrimation, photophobia, and a dull looking cornea (Helmers et al, 1971a).
    2) IRITIS: Ammonia has greater tendency than other alkalies to penetrate and damage the iris, and to cause burns and cataracts in cases of severe exposure. Iritis may be accompanied by hypopyon or hemorrhages, extensive loss of pigment, and severe glaucoma (Grant, 1993).
    3) CONJUNCTIVITIS, lacrimation, palpebral edema, blepharospasm, photophobia, corneal irritation, and temporary blindness are common after severe exposure (Hughes, 1946a) 1946b; (Millea et al, 1989; HSDB , 2001).
    4) CORNEAL DEFECTS: Corneal epithelial defects, including total epithelial loss of the cornea may occur following severe exposure (Close et al, 1980). Ammonium hydroxide is lipid and water soluble which contributes to its penetration into the eye.
    5) IRRITATION: Exposure to ammonia is very irritating to the eyes and upper respiratory tract. Eye irritation begins after exposure to 140 ppm in air, with immediate injury at 700 ppm (Grant, 1993).
    6) INTRAOCULAR PRESSURE ELEVATION: Elevations of intraocular pressure may occur after acute severe exposures (Highman, 1969).
    7) BLINDNESS: Contact with the eye may cause serious eye injury and sometimes permanent blindness (Beare et al, 1988; Hathaway et al, 1996; HSDB , 2001). Injury reported after direct contact to the eye included gross chemosis, corneal staining, loss of pupillary reaction, lens pigmentation, and uveitis, resulting in greatly decreased vision (Clayton & Clayton, 1993).
    8) BURNS of the eyes can occur from exposure to concentrated ammonia vapors (Millea et al, 1989).
    9) CORNEAL OPACITY: Rabbits exposed to 470 mg/m(3) of ammonia for 90 days developed erythema, discharge, and corneal opacity (Clayton & Clayton, 1993).
    3.4.5) NOSE
    A) WITH POISONING/EXPOSURE
    1) IRRITATION: Erythema and edema of the nasal passages, soft palate, posterior pharyngeal wall and larynx are common (Close et al, 1980; Millea et al, 1989).
    2) BURNS: Inhalation of concentrated ammonia vapor may cause irritation, dryness, and mucosal burns (Millea et al, 1989; Hathaway et al, 1996).
    3.4.6) THROAT
    A) WITH POISONING/EXPOSURE
    1) BURNS: Inhalation of concentrated ammonia vapors results in mucosal burns of the pharynx and larynx which may cause laryngeal edema (Close et al, 1980; Millea et al, 1989). Throat irritation occurs at about 400 ppm exposure and laryngospasm at 1,700 ppm exposure (Helmers et al, 1971).
    a) CASE SERIES: Three children who accidentally bit into capsule of aromatic ammonia (glass capsule containing a fiber mesh and 0.33 milliliters of 18% ammonia and 36% ethanol) developed burns of the lips and tongue without involvement of the esophagus (Wason et al, 1990). The small volume of liquid contained in these makes esophageal injury unlikely.
    2) EDEMA: After direct exposure to ammonia solution, the glottis and nasopharynx were reportedly extremely swollen, enough so as to prevent swallowing (Clayton & Clayton, 1993).

Cardiovascular

    3.5.3) ANIMAL EFFECTS
    A) ANIMAL STUDIES
    1) MYOCARDITIS
    a) FIBROSIS: RATS continuously exposed to 470 mg/m(3) of ammonia for 90 days developed myocardial fibrosis (HSDB , 1992).

Respiratory

    3.6.2) CLINICAL EFFECTS
    A) DYSPNEA
    1) WITH POISONING/EXPOSURE
    a) Ammonia exposure may cause bronchospasm, laryngitis, tracheitis, wheezing, dyspnea, cough, hemoptysis, chest pain, cyanosis, and laryngeal stridor (Boyd et al, 1944; Caplin, 1941; Helmers et al, 1971; Birken et al, 1981; Kocks & Scott, 1990).
    B) INJURY OF UPPER RESPIRATORY TRACT
    1) WITH POISONING/EXPOSURE
    a) MUCOSAL BURNS: Inhalation of (concentrated) ammonia vapors may cause mucosal burns to the tracheobronchial tree (Close et al, 1980; Millea et al, 1989).
    b) CASE REPORT: A 28-year-old man developed pharyngeal and laryngeal edema and severe tracheobronchial burns after exposure to high concentrations of anhydrous ammonia (Leduc et al, 1992). He developed dyspnea, chest tightness and copious bronchial secretions and expectorated a large cast of burned tracheobronchial mucosa.
    C) IRRITATION SYMPTOM
    1) WITH POISONING/EXPOSURE
    a) Inhalation of vapors from household ammonia (5% to 10% ammonia) is irritating to the eyes and upper respiratory tract (Ziarnik et al, 1986).
    b) CASE SERIES: Volunteers exposed to ammonia vapor for 2 hours at concentrations of 50, 80, 110, and 140 ppm experienced no effects on ventilatory capacity or 1-second expiratory and inspiratory volumes. Half of the volunteers found irritation from 140 ppm so severe that they terminated exposure prematurely (Clayton & Clayton, 1993).
    c) CASE SERIES: Volunteers exposed to 35 mg/m(3) for 5 minutes reported no irritation of the eyes, nose, throat, or chest (Clayton & Clayton, 1993).
    d) CASE REPORT: A 5-minute exposure to 94 mg/m(3) caused chest irritation in 1 volunteer (Clayton & Clayton, 1993).
    D) ACUTE LUNG INJURY
    1) WITH POISONING/EXPOSURE
    a) Pulmonary edema, bronchiectasis, and hypoxemia may occur following exposure to concentrated ammonia vapors (Boyd et al, 1944; Caplin, 1941; Hathaway et al, 1996; Levy et al, 1964; Kocks & Scott, 1990) (Sittig, 1991).
    1) CASE REPORT: Three patients exposed to moderate amounts of ammonia gas developed pulmonary edema within 6 hours of hospital admission and died (Caplin, 1941).
    2) CASE REPORT: A worker exposed to ammonia gas died 1 month after exposure. Necropsy findings included acute laryngitis, tracheitis, bronchopneumonia, and pulmonary edema; the kidneys showed early hemorrhagic nephritis and congestion, which were attributed to toxemia secondary to chemical skin burns (HSDB , 2001).
    b) CASE REPORT: A 69-year-old woman developed aspiration pneumonitis and severe corrosive injury to the esophagus and upper airway after swallowing an unknown amount of household ammonia (Klein et al, 1985). She developed non-cardiogenic pulmonary edema and died several days after ingestion.
    E) APNEA
    1) WITH POISONING/EXPOSURE
    a) An initial phase of pulmonary edema, congestion, hemorrhage, and atelectasis may be followed by apparent clinical improvement after 48 to 72 hours, followed by gradual onset of airway obstruction and respiratory failure (Arwood et al, 1985).
    F) CHRONIC OBSTRUCTIVE LUNG DISEASE
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 41-year-old man, who was a Jehovah's Witness, developed severe respiratory distress following exposure to anhydrous ammonia after an explosion occurred at his job. He presented with second degree burns to his face, neck, and upper chest, and corneal damage. An initial bronchoscopy showed diffuse erythema of his airway and fibrinous exudates. During his hospital course, he developed bilateral deep venous thromboses and bilateral pulmonary emboli, despite prophylactic anticoagulation with warfarin. Following successful decannulation after a prolonged period of mechanical ventilation, dyspnea on exertion continued to persist, and pulmonary function tests determined the development of chronic obstructive pulmonary disease. Despite supportive care and intensive pulmonary rehabilitation, the patient's condition continued to deteriorate and a double-lung transplant was indicated. Due to his religious practices, he underwent a double-lung transplant without the use of blood products. His lung transplant appeared to be successful, with pulmonary function tests showing significant improvement, and an improvement in the patient's quality of life (Ortiz-Pujols et al, 2014).
    G) RESPIRATORY FINDING
    1) CHRONIC TOXICITY
    a) VENTILATORY AND DIFFUSION ABNORMALITIES: Chronic exposure in workers may lead to initial complaints of chronic cough, dyspnea on effort, bilateral infiltrates on chest x-ray, and lung function indices reflecting ventilatory and diffusion abnormalities (Proctor et al, 1988). After three years away from ammonia exposure, some workers have had persistent evidence of pulmonary damage (Finkel, 1983; Proctor et al, 1988)
    2) PULMONARY FIBROSIS
    a) CHRONIC TOXICITY
    1) CASE REPORT: Workplace exposure in a 54-year-old custodian using a diluted 28% ammonium hydroxide solution to clean floors daily for 19 years was associated with interstitial lung fibrosis (Kollef, 1987).
    2) CASE REPORT: A 68-year-old man who was exposed to ammonia gas for 18 years at work, developed interstitial pulmonary fibrosis (Brautbar et al, 2003).
    3) COUGHING
    a) CHRONIC TOXICITY
    1) CASE REPORT: Chronic cough and increasing dyspnea were reported in a man working in a walk-in refrigerator; lung function indices reflected both ventilatory and diffusion abnormalities, and bilateral infiltrates were seen on chest x-ray (Finkel, 1983).
    b) BRONCHOSPASM
    1) CHRONIC TOXICITY
    a) CASE SERIES: Asthma and laryngitis have been reported in workers chronically exposed to ammonia (Andanson et al, 1976).
    b) Chronic exposure in workers may lead to initial complaints of chronic cough and dyspnea on effort. Bilateral infiltrates on chest x-ray, and lung function indices reflect ventilatory and diffusion abnormalities (Proctor et al, 1988). After three years away from ammonia exposure, some workers have had persistent evidence of pulmonary damage (Finkel, 1983; Proctor et al, 1988).
    H) PNEUMONIA
    1) CHRONIC TOXICITY
    a) CASE REPORT: Direct exposure to an ammonia solution caused chemical pneumonitis (Clayton & Clayton, 1993).
    b) AMMONIA/HYPOCHLORITE: The mixture of ammonia and hypochlorite bleaches results in formation of chloramines, which produce a toxic pneumonitis following inhalation, and may produce residual pulmonary function abnormalities (Reisz & Gammon, 1986; Faigel, 1964; Gapany-Gapanavicius et al, 1982).
    I) LARYNGISMUS
    1) CHRONIC TOXICITY
    a) Death can result from exposure to 5000 ppm from laryngospasm, inflammation, or laryngeal edema.
    J) HYPOVENTILATION
    1) CHRONIC TOXICITY
    a) During controlled human exposures at approximately 500 ppm for 30 minutes, irregular minute ventilation with a cyclic pattern of hyperpnea has been noted (HSDB , 2001).
    K) DISORDER OF RESPIRATORY SYSTEM
    1) CHRONIC TOXICITY
    a) OBSTRUCTIVE PULMONARY DISEASE has been reported.
    1) CASE REPORT: Persistent obstructive pulmonary disease has been reported after a single severe inhalational exposure to anhydrous ammonia gas (Leduc et al, 1992).
    a) Reduced mucociliary clearance, bronchiectasis, persistent bronchial inflammation, cough, exertional dyspnea and recurrent bronchial infections persisted during 10 years of follow up in this patient.
    2) In a study evaluating pulmonary function in fire fighters, those with a self-reported history of exposure to ammonia had a more rapid rate of decline of FEV1 than those without ammonia exposure (Tepper et al, 1991).
    3.6.3) ANIMAL EFFECTS
    A) ANIMAL STUDIES
    1) DEATH
    a) Exposure of experimental animals to ammonia at 7000 mg/m(3) for 1 hour resulted in death in approximately 50% of the animals.
    1) Necropsy revealed severe effects on the upper respiratory tract. Effects found in the lower respiratory tract included damage to the bronchioles and alveolar congestion, edema, atelectasis, hemorrhage, emphysema, and fluid (Clayton & Clayton, 1981).

Neurologic

    3.7.2) CLINICAL EFFECTS
    A) CENTRAL NERVOUS SYSTEM DEFICIT
    1) WITH POISONING/EXPOSURE
    a) An altered mental status, including coma may occur and is probably secondary to hypoxia from ammonia-induced respiratory injury.
    B) SEIZURE
    1) WITH POISONING/EXPOSURE
    a) If there is extensive absorption, hypertonus and convulsions may occur (HSDB , 2001).
    C) TOXIC ENCEPHALOPATHY
    1) WITH POISONING/EXPOSURE
    a) Encephalopathy was observed in 3 of 8 patients receiving glycine irrigation following transurethral prostatectomy (Shepard et al, 1987).
    3.7.3) ANIMAL EFFECTS
    A) ANIMAL STUDIES
    1) SEIZURES
    a) PIGS: One pig exposed to 280 ppm of ammonia had convulsions after 36 hours of exposure, which continued for 3 hours after exposure had ended (HSDB , 1992).

Gastrointestinal

    3.8.2) CLINICAL EFFECTS
    A) GASTROINTESTINAL IRRITATION
    1) WITH POISONING/EXPOSURE
    a) Irritant effects including nausea, vomiting, burning sensation. Swelling of the lips, mouth, and larynx have been reported.
    B) CHEMICAL BURN
    1) WITH POISONING/EXPOSURE
    a) Oral and esophageal burns may occur with swallowed household ammonia, particularly if ingestion is deliberate. Esophageal burns were reported in three adults who ingested household ammonia products (containing 3% to 3.6% ammonia at a pH of 11.5 to 11.8) in suicidal attempts (Klein et al, 1985).
    b) CASE SERIES: Ingestion of milk contaminated with 530 to 1524 ppm ammonia (pH 9 to 10) in 20 children resulted in nausea and severe burning of the mouth and throat (Ziarnik et al, 1986).
    C) STRICTURE OF ESOPHAGUS
    1) WITH POISONING/EXPOSURE
    a) Ingestion of concentrated ammonia may produce ulcerative esophagitis with late strictures (Gossot et al, 1990).
    b) Gastric, duodenal, and jejunal stenosis have also resulted. Unrecognized late strictures may be confused with malignant growths (O'Donnell et al, 1949); (Cardona & Daly, 1964).
    D) GASTRITIS
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: Severe gastritis has been reported following a sudden and massive inhalation of ammonia. Symptoms included abdominal pain, and nausea (Dupuy et al, 1968).
    E) GASTRIC ULCER WITH PERFORATION
    1) WITH POISONING/EXPOSURE
    a) Oral and esophageal burns or esophageal and gastric perforation within 24 to 72 hours leading to mediastinitis have been reported.
    F) SERUM AMYLASE RAISED
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: Hyperamylasemia was reported in 2 fatal cases of industrial ammonia liquid inhalation (Arwood et al, 1985).
    G) NAUSEA AND VOMITING
    1) WITH POISONING/EXPOSURE
    a) FOOD POISONING: An outbreak of gastrointestinal illness occurred after students were served chicken tenders that were contaminated with ammonia. Onset of illness was within 180 minutes of eating lunch. Symptoms included stomachache in 82%, headache in 61%, nausea in 41%, and vomiting in 23% of the children. A warehouse leak of ammonia refrigerant was the cause of the contamination. Levels as high as 2,468 ppm were detected in the uncooked chicken tenders (Dworkin et al, 2004).

Hepatic

    3.9.3) ANIMAL EFFECTS
    A) ANIMAL STUDIES
    1) HEPATOCELLULAR DAMAGE
    a) Guinea pigs were exposed to approximately 170 ppm of ammonia for 6 hours/day, 5 days a week, for 18 weeks; congestion of the liver was seen at autopsy (HSDB , 1992).

Genitourinary

    3.10.2) CLINICAL EFFECTS
    A) RETENTION OF URINE
    1) WITH POISONING/EXPOSURE
    a) Urinary retention may occur after acute inhalation exposure (HSDB , 2001).
    3.10.3) ANIMAL EFFECTS
    A) ANIMAL STUDIES
    1) RENAL TUBULAR DISORDER
    a) Rats exposed to 470 mg/m(3) of ammonia for 90 days developed calcification and epithelial proliferation of the renal tubules (HSDB , 1992).
    2) RENAL FUNCTION ABNORMAL
    a) Guinea pigs were exposed to approximately 170 ppm of ammonia for 6 hours/day, 5 days a week, for 18 weeks; congestion of the kidneys and degenerative changes in the suprarenal glands were seen at autopsy (HSDB , 1992).

Hematologic

    3.13.3) ANIMAL EFFECTS
    A) ANIMAL STUDIES
    1) LEUKOPENIA
    a) The effects of the addition of ammonia into tissue cultures in bovine blood during clinical and subclinical urea toxicosis were studied. Approximately 30% of the bovine lymphocytes were killed by ammonia during 72 hours of incubation (HSDB , 1992).

Dermatologic

    3.14.2) CLINICAL EFFECTS
    A) CHEMICAL BURN
    1) WITH POISONING/EXPOSURE
    a) Skin and eye exposure cause vesiculation and corrosive burns which feel soapy due to saponification of fat in the tissue (Dalton & Bricker, 1978). Ammonia acts as an alkali, producing liquefaction necrosis, deep penetrating burns, and scarring (Cordona & Daly, 1964; (Chassin & Slattery, 1953).
    b) Extensive burns of the face and mouth occurred following direct exposure to an ammonia solution (Clayton & Clayton, 1993).
    c) Less severe skin injury may appear as grey-yellow, soft regions (Millea et al, 1989). More severe skin injury may appear as black, leathery tissue (Millea et al, 1989; Birken et al, 1981).
    B) URTICARIA
    1) WITH POISONING/EXPOSURE
    a) Hives and urticaria have been reported (HSDB , 1992).
    C) FROSTBITE
    1) WITH POISONING/EXPOSURE
    a) Exposure to anhydrous ammonia stored at minus 28 degrees F may produce frostbite injury with thrombosis of surface vessels and subsequent ischemia and necrosis (Millea et al, 1989; AAR, 1987).
    D) DERMATITIS
    1) WITH POISONING/EXPOSURE
    a) CHRONIC EXPOSURE: Dermatitis has been reported in chronically exposed workers (Andanson et al, 1976).

Endocrine

    3.16.3) ANIMAL EFFECTS
    A) ANIMAL STUDIES
    1) ENDOCRINE DISORDER
    a) Adrenocortical system changes were investigated in an enclosed atmosphere; the most pronounced changes were noted when the ammonia content was 5 mg/m(3) (HSDB , 2001).
    2) HYPERGLYCEMIA
    a) Results of a study in steers suggested that the hyperglycemia observed during hyperammonemia may result from an under-utilization of glucose by insulin-sensitive tissues (Fernandez et al, 1988).

Reproductive

    3.20.1) SUMMARY
    A) At the time of this review, no data were available to assess the teratogenic potential of this agent.
    B) Decreased egg production has occurred in experimental animals. Ammonia crosses the ovine placental barrier.
    C) At the time of this review, no data were available to assess the potential effects of exposure to this agent during lactation.
    D) No information about possible male reproductive effects was found in available references at the time of this review.
    3.20.2) TERATOGENICITY
    A) LACK OF INFORMATION
    1) At the time of this review, no data were available to assess the teratogenic potential of this agent.
    B) ANIMAL STUDIES
    1) One study was reported in which the reproductive effects of ammonium chloride were examined in laboratory animals (Caros, 1978). High doses of ammonia itself are impossible to achieve in a reproductive study because of its strong corrosive effects. Pregnant rats were injected intramuscularly with 1.5-2 mL of a 1% solution of AMMONIUM CHLORIDE daily during the last 10 days of pregnancy. This treatment reduced the number of live births and body weight in the pups, and produced dystrophic changes in the central nervous system. Because the route of administration would not be encountered in the occupational setting and the possibility that the large volumes administered may have altered the osmotic or fluid balance in the rats, the results of this study are difficult to relate to occupational ammonia exposure.
    3.20.3) EFFECTS IN PREGNANCY
    A) PLACENTAL BARRIER
    1) BIRD/ANIMAL - Decreased egg production has occurred in birds and pullets. Ammonia crosses the ovine placental barrier (HSDB , 2001).
    B) ANIMAL STUDIES
    1) Ammonia can reach the fetus from production within the uteroplacenta, and ammonia concentrations in the umbilical were approximately twice that of normal adult levels, as measured in 96 deliveries (Desanto et al, 1993).
    2) In sheep, the fetus has been reported to be less sensitive to ammonia than the dam (HSDB , 2001).
    3.20.4) EFFECTS DURING BREAST-FEEDING
    A) LACK OF INFORMATION
    1) At the time of this review, no data were available to assess the potential effects of exposure to ammonia during lactation.

Carcinogenicity

    3.21.1) IARC CATEGORY
    A) IARC Carcinogenicity Ratings for CAS7664-41-7 (International Agency for Research on Cancer (IARC), 2016; International Agency for Research on Cancer, 2015; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010a; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2008; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2006; IARC, 2004):
    1) Not Listed
    3.21.3) HUMAN STUDIES
    A) LACK OF INFORMATION
    1) At the time of this review, no data were available to assess the carcinogenic potential of this agent.

Genotoxicity

    A) Mutations have been detected in E. coli. Chromosome aberration were detected by cytogenetic analysis in rat studies.

Monitoring Parameters Levels

    4.1.1) SUMMARY
    A) Obtain a complete blood count in symptomatic patients following an ammonia ingestion.
    B) In patients with signs and symptoms suggesting severe burns, perforation, or bleeding (or adults with deliberate, high volume or high concentration ingestions), obtain renal function tests, serum electrolytes, INR, PTT, type and crossmatch for blood, and monitor urine output. Serum lactate and base deficit may also be useful in these patients.
    C) Monitor pulse oximetry or arterial blood gases in patients with signs and symptoms suggestive of upper airway edema or burns.
    D) Obtain an upright chest x-ray in patients with signs and symptoms suggesting severe burns, perforation, or bleeding (or adults with deliberate, high volume or high concentration ingestions) to evaluate for pneumomediastinum or free air under the diaphragm. The absence of these findings DOES NOT rule out the possibility of necrosis or perforation of the esophagus or stomach. Obtain a chest radiograph in patients with pulmonary signs or symptoms.
    E) Several weeks after ingestion, barium contrast radiographs of the upper GI tract are useful in patients who sustained grade II or III burns, to evaluate for strictures.
    4.1.2) SERUM/BLOOD
    A) HEMATOLOGIC
    1) Obtain a complete blood count in patients with symptomatic ammonia ingestion.
    B) COAGULATION STUDIES
    1) In patients with signs and symptoms suggesting severe burns, perforation, or bleeding, obtain renal function tests, PT or INR, PTT, and type and crossmatch for blood.
    C) BLOOD/SERUM CHEMISTRY
    1) Ammonia is normally found in human blood at a concentration of 80 to 110 mcg/dL (Braunwald et al, 1987).
    a) A serum concentration of 1,000 to 10,000 mcg/dL is considered toxic.
    2) There can be a fourfold or greater rise in blood ammonia in some toxic liver diseases because the urease needed to convert ammonia to urea is found only in the liver (Smith, 1990).
    4.1.3) URINE
    A) URINARY LEVELS
    1) Inhalation of concentrated ammonia vapors may produce considerable degradation of collagen resulting in elevated urinary metabolites of hydroxylysine (Hatton et al, 1979).
    B) OTHER
    1) Monitor urine output in patients with significant gastrointestinal burns, perforation, or bleeding.
    4.1.4) OTHER
    A) OTHER
    1) MONITORING
    a) Monitor pulse oximetry or arterial blood gases in patients with signs and symptoms suggestive of upper airway burns.
    b) Endoscopy is recommended following ingestions in symptomatic patients or those swallowing large amounts or solutions with high concentrations of ammonia.

Radiographic Studies

    A) CHEST RADIOGRAPH
    1) Obtain an upright chest x-ray in patients with significant signs and symptoms to evaluate for pneumomediastinum or free air under the diaphragm.
    2) The absence of these findings does not rule out the possibility of necrosis or perforation of the esophagus or stomach (Davis et al, 1972; Allen et al, 1970).
    3) Obtain a chest x-ray in patients with significant pulmonary signs or symptoms
    4) A water-soluble contrast material should be used initially to exclude esophageal perforation in patients with GI burns associated with alkaline ingestions, as water soluble contrast causes less injury than barium if it extravasates into tissue (Kirsh & Ritter, 1976; Chen et al, 1988).
    5) Barium esophagogram performed once perforation has been excluded may be useful to evaluate extent of injury or presence of strictures (Leape et al, 1971; Lowe et al, 1979; Chen et al, 1988).
    B) RADIOGRAPHIC-OTHER
    1) Radionuclide lung imaging may be useful in evaluating obstructive lung disease if chronic respiratory symptoms develop after acute exposure to ammonia (Taplin et al, 1976).

Methods

    A) OTHER
    1) Identification can be made by the strong, pungent, penetrating odor. Ammonia turns litmus paper blue. Concentrated hydrochloric acid near a suspected NH3 solution will produce copious fumes of ammonium chloride.
    2) Adding chloroplantinic acid solution produces typical crystals and adding Nessler's reagent yields a yellow-orange color.
    3) The determination of ammonia in air may be done using an ammonia-specific electrode, second derivatives spectroscopy, ion chromatography, or colorimetrically (HSDB , 2001).

Life Support

    A) Support respiratory and cardiovascular function.

Patient Disposition

    6.3.1) DISPOSITION/ORAL EXPOSURE
    6.3.1.1) ADMISSION CRITERIA/ORAL
    A) Symptomatic patients, and those with endoscopically demonstrated grade II or higher burns should be admitted. Patients with respiratory distress, grade III burns, acidosis, hemodynamic instability, gastrointestinal bleeding, or large ingestions should be admitted to an intensive care setting.
    6.3.1.5) OBSERVATION CRITERIA/ORAL
    A) Patients with ammonia ingestion should be sent to a health care facility for evaluation. Patients who remain asymptomatic over 4 to 6 hours of observation, and those with endoscopic evaluation that demonstrates no burns or only minor grade I burns and who can tolerate oral intake can be discharged home.

Monitoring

    A) Obtain a complete blood count in symptomatic patients following an ammonia ingestion.
    B) In patients with signs and symptoms suggesting severe burns, perforation, or bleeding (or adults with deliberate, high volume or high concentration ingestions), obtain renal function tests, serum electrolytes, INR, PTT, type and crossmatch for blood, and monitor urine output. Serum lactate and base deficit may also be useful in these patients.
    C) Monitor pulse oximetry or arterial blood gases in patients with signs and symptoms suggestive of upper airway edema or burns.
    D) Obtain an upright chest x-ray in patients with signs and symptoms suggesting severe burns, perforation, or bleeding (or adults with deliberate, high volume or high concentration ingestions) to evaluate for pneumomediastinum or free air under the diaphragm. The absence of these findings DOES NOT rule out the possibility of necrosis or perforation of the esophagus or stomach. Obtain a chest radiograph in patients with pulmonary signs or symptoms.
    E) Several weeks after ingestion, barium contrast radiographs of the upper GI tract are useful in patients who sustained grade II or III burns, to evaluate for strictures.

Oral Exposure

    6.5.1) PREVENTION OF ABSORPTION/PREHOSPITAL
    A) DILUTION
    1) Residual ammonia in and around the mouth should be rinsed with milk or water.
    2) If no respiratory compromise is present, administer milk or water as soon as possible after ingestion. The exact ideal amount is unknown; no more than 8 ounces (240 mL) in adults and 4 ounces (120 mL) in children is recommended to minimize the risk of vomiting (Caravati, 2004).
    3) USE OF DILUENTS IS CONTROVERSIAL: While experimental models have suggested that immediate dilution may lessen caustic injury (Homan et al, 1993; Homan et al, 1994; Homan et al, 1995), this has not been adequately studied in humans.
    4) DILUENT TYPE: Use any readily available nontoxic, cool liquid. Both milk and water have been shown to be effective in experimental studies of caustic ingestion (Maull et al, 1985; Rumack & Burrington, 1977a; Homan et al, 1995; Homan et al, 1994; Homan et al, 1993).
    5) ADVERSE EFFECTS: Potential adverse effects include vomiting and airway compromise (Caravati, 2004).
    6) CONTRAINDICATIONS: Do NOT attempt dilution in patients with respiratory distress, altered mental status, severe abdominal pain, nausea or vomiting, or patients who are unable to swallow or protect their airway. Diluents should not be force fed to any patient who refuses to swallow (Rao & Hoffman, 2002).
    B) There is no specific antidote for ammonia poisoning ((ATSDR, 1999)).
    C) ACTIVATED CHARCOAL
    1) Activated charcoal is of no benefit, and may induce vomiting and obscure endoscopy findings. It is NOT recommended.
    6.5.2) PREVENTION OF ABSORPTION
    A) SUMMARY
    1) Do not perform gastric lavage.
    B) NEUTRALIZATION
    1) Do not attempt to neutralize "basic" ingestions with acids.
    C) DILUTION
    1) THE USE OF DILUENTS IS CONTROVERSIAL. Immediate dilution with small amounts of milk or water may help decontaminate the oral mucosa.
    a) In a survey of the POISINDEX(R) editorial board (Consensus, 1988), 7 of 10 members routinely recommended dilution, provided that no airway compromise was present. Two other members expressed concern that dilution might precipitate vomiting, but this was not the experience of other members.
    2) ADVERSE EFFECTS OF DILUTION
    a) In a series of 22 cases of corrosive ingestions, 4 of 7 patients treated with dilution vomited. None of the 15 patients not given fluids vomited. One patient suffered severe consequences following vomiting after 6 ounces of milk. A 3-year-old child died after one glass of milk caused vomiting (Honcharak & Marcus, 1989).
    3) DILUENT TYPE
    a) Swallowed milk may obscure esophagoscopy (Howell, 1987), but is not a problem with equipment containing water irrigation attachments. Maull (1985) found water to be an ineffective diluent in vitro. Other in vitro work has demonstrated efficacy of milk or water (Rumack & Burrington, 1977).
    4) DILUENT AMOUNT
    a) The amount of diluent recommended by the POISINDEX(R) editorial board varied widely, ranging from 2 to 12 ounces in adults and 1 to 8 ounces in children. The majority recommended a maximum amount of 8 ounces in adults and 4 ounces in children (Consensus, 1988).
    D) NASOGASTRIC SUCTION
    1) INDICATIONS: Consider insertion of a small, flexible nasogastric tube to aspirate gastric contents after large, recent ingestion of caustics. The risk of worsening mucosal injury (including perforation) must be weighed against the potential benefit.
    2) PRECAUTIONS:
    a) SEIZURE CONTROL: Is mandatory prior to gastric emptying.
    b) AIRWAY PROTECTION: Alert patients - place in Trendelenburg and left lateral decubitus position, with suction available. Obtunded or unconscious patients - cuffed endotracheal intubation. COMPLICATIONS:
    1) Complications of gastric aspiration may include: aspiration pneumonia, hypoxia, hypercapnia, mechanical injury to the throat, esophagus, or stomach (Vale, 1997). Combative patients may be at greater risk for complications.
    6.5.3) TREATMENT
    A) AIRWAY MANAGEMENT
    1) Intubation (preferred method) or tracheostomy may be life-saving following severe exposure if stridor, indicating laryngeal edema, is present (Close et al, 1980; Millea et al, 1989).
    2) If serious respiratory tract burns have occurred, sloughed mucosa of the major airways must be removed (Close et al, 1980).
    B) OXYGEN
    1) If necessary, administer oxygen as needed.
    C) ACUTE LUNG INJURY
    1) ONSET: Onset of acute lung injury after toxic exposure may be delayed up to 24 to 72 hours after exposure in some cases.
    2) NON-PHARMACOLOGIC TREATMENT: The treatment of acute lung injury is primarily supportive (Cataletto, 2012). Maintain adequate ventilation and oxygenation with frequent monitoring of arterial blood gases and/or pulse oximetry. If a high FIO2 is required to maintain adequate oxygenation, mechanical ventilation and positive-end-expiratory pressure (PEEP) may be required; ventilation with small tidal volumes (6 mL/kg) is preferred if ARDS develops (Haas, 2011; Stolbach & Hoffman, 2011).
    a) To minimize barotrauma and other complications, use the lowest amount of PEEP possible while maintaining adequate oxygenation. Use of smaller tidal volumes (6 mL/kg) and lower plateau pressures (30 cm water or less) has been associated with decreased mortality and more rapid weaning from mechanical ventilation in patients with ARDS (Brower et al, 2000). More treatment information may be obtained from ARDS Clinical Network website, NIH NHLBI ARDS Clinical Network Mechanical Ventilation Protocol Summary, http://www.ardsnet.org/node/77791 (NHLBI ARDS Network, 2008)
    3) FLUIDS: Crystalloid solutions must be administered judiciously. Pulmonary artery monitoring may help. In general the pulmonary artery wedge pressure should be kept relatively low while still maintaining adequate cardiac output, blood pressure and urine output (Stolbach & Hoffman, 2011).
    4) ANTIBIOTICS: Indicated only when there is evidence of infection (Artigas et al, 1998).
    5) EXPERIMENTAL THERAPY: Partial liquid ventilation has shown promise in preliminary studies (Kollef & Schuster, 1995).
    6) CALFACTANT: In a multicenter, randomized, blinded trial, endotracheal instillation of 2 doses of 80 mL/m(2) calfactant (35 mg/mL of phospholipid suspension in saline) in infants, children, and adolescents with acute lung injury resulted in acute improvement in oxygenation and lower mortality; however, no significant decrease in the course of respiratory failure measured by duration of ventilator therapy, intensive care unit, or hospital stay was noted. Adverse effects (transient hypoxia and hypotension) were more frequent in calfactant patients, but these effects were mild and did not require withdrawal from the study (Wilson et al, 2005).
    7) However, in a multicenter, randomized, controlled, and masked trial, endotracheal instillation of up to 3 doses of calfactant (30 mg) in adults only with acute lung injury/ARDS due to direct lung injury was not associated with improved oxygenation and longer term benefits compared to the placebo group. It was also associated with significant increases in hypoxia and hypotension (Willson et al, 2015).
    D) MONITORING OF PATIENT
    1) Monitor arterial blood gases following moderate to severe exposure, especially in patients with respiratory symptoms or signs.
    E) BRONCHOSPASM
    1) If bronchospasm and wheezing occur, consider treatment with inhaled sympathomimetic agents.
    F) FLUID/ELECTROLYTE BALANCE REGULATION
    1) Monitor fluid and electrolyte balance and restore if abnormal. Intravenous fluids should be administered cautiously in patients with pulmonary edema.
    G) ENDOSCOPIC PROCEDURE
    1) SUMMARY: Obtain consultation concerning endoscopy as soon as possible, and perform endoscopy within the first 24 hours when indicated.
    2) INDICATIONS: Endoscopy should be performed in adults with a history of deliberate ingestion, adults with any signs or symptoms attributable to inadvertent ingestion, and in children with stridor, vomiting, or drooling after unintentional ingestion (Crain et al, 1984). Endoscopy should also be performed in children with dysphagia or refusal to swallow, significant oral burns, or abdominal pain after unintentional ingestion (Gaudreault et al, 1983; Nuutinen et al, 1994). Children and adults who are asymptomatic after accidental ingestion do not require endoscopy (Gupta et al, 2001; Lamireau et al, 2001; Gorman et al, 1992).
    3) RISKS: Numerous large case series attest to the relative safety and utility of early endoscopy in the management of caustic ingestion.
    a) REFERENCES: (Dogan et al, 2006; Symbas et al, 1983; Crain et al, 1984a; Gaudreault et al, 1983a; Schild, 1985; Moazam et al, 1987; Sugawa & Lucas, 1989; Previtera et al, 1990; Zargar et al, 1991; Vergauwen et al, 1991; Gorman et al, 1992)
    4) The risk of perforation during endoscopy is minimized by (Zargar et al, 1991):
    a) Advancing across the cricopharynx under direct vision
    b) Gently advancing with minimal air insufflation
    c) Never retroverting or retroflexing the endoscope
    d) Using a pediatric flexible endoscope
    e) Using extreme caution in advancing beyond burn lesion areas
    f) Most authors recommend endoscopy within the first 24 hours of injury, not advancing the endoscope beyond areas of severe esophageal burns, and avoiding endoscopy during the subacute phase of healing when tissue slough increases the risk of perforation (5 to 15 days after ingestion) (Zargar et al, 1991).
    5) GRADING
    a) Several scales for grading caustic injury exist. The likelihood of complications such as strictures, obstruction, bleeding, and perforation is related to the severity of the initial burn (Zargar et al, 1991):
    b) Grade 0 - Normal examination
    c) Grade 1 - Edema and hyperemia of the mucosa; strictures unlikely.
    d) Grade 2A - Friability, hemorrhages, erosions, blisters, whitish membranes, exudates and superficial ulcerations; strictures unlikely.
    e) Grade 2B - Grade 2A plus deep discreet or circumferential ulceration; strictures may develop.
    f) Grade 3A - Multiple ulcerations and small scattered areas of necrosis; strictures are common, complications such as perforation, fistula formation or gastrointestinal bleeding may occur.
    g) Grade 3B - Extensive necrosis through visceral wall; strictures are common, complications such as perforation, fistula formation, or gastrointestinal bleeding are more likely than with 3A.
    6) FOLLOW UP - If burns are found, follow 10 to 20 days later with barium swallow or esophagram.
    7) SCINTIGRAPHY - Scans utilizing radioisotope labelled sucralfate (technetium 99m) were performed in 22 patients with caustic ingestion and compared with endoscopy for the detection of esophageal burns. Two patients had minimal residual isotope activity on scanning but normal endoscopy and two patients had normal activity on scan but very mild erythema on endoscopy. Overall the radiolabeled sucralfate scan had a sensitivity of 100%, specificity of 81%, positive predictive value of 84% and negative predictive value of 100% for detecting clinically significant burns in this population (Millar et al, 2001). This may represent an alternative to endoscopy, particularly in young children, as no sedation is required for this procedure. Further study is required.
    8) MINIPROBE ULTRASONOGRAPHY - was performed in 11 patients with corrosive ingestion . Findings were categorized as grade 0 (distinct muscular layers without thickening, grade I (distinct muscular layers with thickening), grade II (obscured muscular layers with indistinct margins) and grade III (muscular layers that could not be differentiated). Findings were further categorized as to whether the worst appearing image involved part of the circumference (type a) or the whole circumference (type b). Strictures did not develop in patients with grade 0 (5 patients) or grade I (4 patients) lesions. Transient stricture formation developed in the only patient with grade IIa lesions, and stricture requiring repeated dilatation developed in the only patient with grade IIIb lesions (Kamijo et al, 2004).
    H) CORTICOSTEROID
    1) CORROSIVE INGESTION/SUMMARY: The use of corticosteroids for the treatment of caustic ingestion is controversial. Most animal studies have involved alkali-induced injury (Haller & Bachman, 1964; Saedi et al, 1973). Most human studies have been retrospective and generally involve more alkali than acid-induced injury and small numbers of patients with documented second or third degree mucosal injury.
    2) FIRST DEGREE BURNS: These burns generally heal well and rarely result in stricture formation (Zargar et al, 1989; Howell et al, 1992). Corticosteroids are generally not beneficial in these patients (Howell et al, 1992).
    3) SECOND DEGREE BURNS: Some authors recommend corticosteroid treatment to prevent stricture formation in patients with a second degree, deep-partial thickness burn (Howell et al, 1992). However, no well controlled human study has documented efficacy. Corticosteroids are generally not beneficial in patients with a second degree, superficial-partial thickness burn (Caravati, 2004; Howell et al, 1992).
    4) THIRD DEGREE BURNS: Some authors have recommended steroids in this group as well (Howell et al, 1992). A high percentage of patients with third degree burns go on to develop strictures with or without corticosteroid therapy and the risk of infection and perforation may be increased by corticosteroid use. Most authors feel that the risk outweighs any potential benefit and routine use is not recommended (Boukthir et al, 2004; Oakes et al, 1982; Pelclova & Navratil, 2005).
    5) CONTRAINDICATIONS: Include active gastrointestinal bleeding and evidence of gastric or esophageal perforation. Corticosteroids are thought to be ineffective if initiated more than 48 hours after a burn (Howell, 1987).
    6) DOSE: Administer daily oral doses of 0.1 milligram/kilogram of dexamethasone or 1 to 2 milligrams/kilogram of prednisone. Continue therapy for a total of 3 weeks and then taper (Haller et al, 1971; Marshall, 1979). An alternative regimen in children is intravenous prednisolone 2 milligrams/kilogram/day followed by 2.5 milligrams/kilogram/day of oral prednisone for a total of 3 weeks then tapered (Anderson et al, 1990).
    7) ANTIBIOTICS: Animal studies suggest that the addition of antibiotics can prevent the infectious complications associated with corticosteroid use in the setting of caustic burns. Antibiotics are recommended if corticosteroids are used or if perforation or infection is suspected. Agents that cover anaerobes and oral flora such as penicillin, ampicillin, or clindamycin are appropriate (Rosenberg et al, 1953).
    8) STUDIES
    a) ANIMAL
    1) Some animal studies have suggested that corticosteroid therapy may reduce the incidence of stricture formation after severe alkaline corrosive injury (Haller & Bachman, 1964; Saedi et al, 1973a).
    2) Animals treated with steroids and antibiotics appear to do better than animals treated with steroids alone (Haller & Bachman, 1964).
    3) Other studies have shown no evidence of reduced stricture formation in steroid treated animals (Reyes et al, 1974). An increased rate of esophageal perforation related to steroid treatment has been found in animal studies (Knox et al, 1967).
    b) HUMAN
    1) Most human studies have been retrospective and/or uncontrolled and generally involve small numbers of patients with documented second or third degree mucosal injury. No study has proven a reduced incidence of stricture formation from steroid use in human caustic ingestions (Haller et al, 1971; Hawkins et al, 1980; Yarington & Heatly, 1963; Adam & Brick, 1982).
    2) META ANALYSIS
    a) Howell et al (1992), analyzed reports concerning 361 patients with corrosive esophageal injury published in the English language literature since 1956 (10 retrospective and 3 prospective studies). No patients with first degree burns developed strictures. Of 228 patients with second or third degree burns treated with corticosteroids and antibiotics, 54 (24%) developed strictures. Of 25 patients with similar burn severity treated without steroids or antibiotics, 13 (52%) developed strictures (Howell et al, 1992).
    b) Another meta-analysis of 10 studies found that in patients with second degree esophageal burns from caustics, the overall rate of stricture formation was 14.8% in patients who received corticosteroids compared with 36% in patients who did not receive corticosteroids (LoVecchio et al, 1996).
    c) Another study combined results of 10 papers evaluating therapy for corrosive esophageal injury in humans published between January 1991 and June 2004. There were a total of 572 patients, all patients received corticosteroids in 6 studies, in 2 studies no patients received steroids, and in 2 studies, treatment with and without corticosteroids was compared. Of 109 patients with grade 2 esophageal burns who were treated with corticosteroids, 15 (13.8%) developed strictures, compared with 2 of 32 (6.3%) patients with second degree burns who did not receive steroids (Pelclova & Navratil, 2005).
    3) Smaller studies have questioned the value of steroids (Ferguson et al, 1989; Anderson et al, 1990), thus they should be used with caution.
    4) Ferguson et al (1989) retrospectively compared 10 patients who did not receive antibiotics or steroids with 31 patients who received both antibiotics and steroids in a study of caustic ingestion and found no difference in the incidence of esophageal stricture between the two groups (Ferguson et al, 1989).
    5) A randomized, controlled, prospective clinical trial involving 60 children with lye or acid induced esophageal injury did not find an effect of corticosteroids on the incidence of stricture formation (Anderson et al, 1990).
    a) These 60 children were among 131 patients who were managed and followed-up for ingestion of caustic material from 1971 through 1988; 88% of them were between 1 and 3 years old (Anderson et al, 1990).
    b) All patients underwent rigid esophagoscopy after being randomized to receive either no steroids or a course consisting initially of intravenous prednisolone (2 milligrams/kilogram per day) followed by 2.5 milligrams/kilogram/day of oral prednisone for a total of 3 weeks prior to tapering and discontinuation (Anderson et al, 1990).
    c) Six (19%), 15 (48%), and 10 (32%) of those in the treatment group had first, second and third degree esophageal burns, respectively. In contrast, 13 (45%), 5 (17%), and 11 (38%) of the control group had the same levels of injury (Anderson et al, 1990).
    d) Ten (32%) of those receiving steroids and 11 (38%) of the control group developed strictures. Four (13%) of those receiving steroids and 7 (24%) of the control group required esophageal replacement. All but 1 of the 21 children who developed strictures had severe circumferential burns on initial esophagoscopy (Anderson et al, 1990).
    e) Because of the small numbers of patients in this study, it lacked the power to reliably detect meaningful differences in outcome between the treatment groups (Anderson et al, 1990).
    6) ADVERSE EFFECTS
    a) The use of corticosteroids in the treatment of caustic ingestion in humans has been associated with gastric perforation (Cleveland et al, 1963) and fatal pulmonary embolism (Aceto et al, 1970).
    I) ANTIBIOTIC
    1) Routine use of antimicrobials as prophylaxis against infection has not been shown to be of benefit. Antibiotics are indicated if perforation or mediastinitis are suspected.
    2) The use of prophylactic antibiotics resulted in infection with resistant organisms in 7 of 29 cases (Close et al, 1980; Flury et al, 1983; Levy et al, 1964; O'Kane, 1983; Pontoppidan et al, 1972).
    J) SURGICAL PROCEDURE
    1) SUMMARY: Initially if severe esophageal burns are found a string may be placed in the stomach to facilitate later dilation. Insertion of a specialized nasogastric tube after confirmation of a circumferential burn may prevent strictures. Dilation is indicated after 2 to 4 weeks if strictures are confirmed. If dilation is unsuccessful colonic intraposition or gastric tube placement may be needed. Early laparotomy should be considered in patients with evidence of severe esophageal or gastric burns on endoscopy.
    2) STRING - If a second degree or circumferential burn of the esophagus is found a string may be placed in the stomach to avoid false channel and to provide a guide for later dilation procedures (Gandhi et al, 1989).
    3) STENT - The insertion of a specialized nasogastric tube or stent immediately after endoscopically proven deep circumferential burns is preferred by some surgeons to prevent stricture formation (Mills et al, 1978; (Wijburg et al, 1985; Coln & Chang, 1986).
    a) STUDY - In a study of 11 children with deep circumferential esophageal burns after caustic ingestion, insertion of a silicone rubber nasogastric tube for 5 to 6 weeks without steroids or antibiotics was associated with stricture formation in only one case (Wijburg et al, 1989).
    4) DILATION - Dilation should be performed at 1 to 4 week intervals when stricture is present(Gundogdu et al, 1992). Repeated dilation may be required over many months to years in some patients. Successful dilation of gastric antral strictures has also been reported (Hogan & Polter, 1986; Treem et al, 1987).
    5) COLONIC REPLACEMENT - Intraposition of colon may be necessary if dilation fails to provide an adequate sized esophagus (Chiene et al, 1974; Little et al, 1988; Huy & Celerier, 1988).
    6) LAPAROTOMY/LAPAROSCOPY - Several authors advocate laparotomy or laparoscopy in patients with endoscopic evidence of severe esophageal or gastric burns to evaluate for the presence of transmural gastric or esophageal necrosis (Cattan et al, 2000; Estrera et al, 1986; Meredith et al, 1988; Wu & Lai, 1993).
    a) STUDY - In a retrospective study of patients with extensive transmural esophageal necrosis after caustic ingestion, all 4 patients treated in the conventional manner (esophagoscopy, steroids, antibiotics, and repeated evaluation for the occurrence of esophagogastric necrosis and perforation) died while all 3 patients treated with early laparotomy and immediate esophagogastric resection survived (Estrera et al, 1986).
    K) TUBE ESOPHAGRAM
    1) Barium esophagram may be indicated to evaluate for stricture formation at 10 to 21 days after ingestion, if initial esophagoscopy has revealed burns.

Inhalation Exposure

    6.7.1) DECONTAMINATION
    A) Move patient from the toxic environment to fresh air. Monitor for respiratory distress. If cough or difficulty in breathing develops, evaluate for hypoxia, respiratory tract irritation, bronchitis, or pneumonitis.
    B) OBSERVATION: Carefully observe patients with inhalation exposure for the development of any systemic signs or symptoms and administer symptomatic treatment as necessary.
    C) INITIAL TREATMENT: Administer 100% humidified supplemental oxygen, perform endotracheal intubation and provide assisted ventilation as required. Administer inhaled beta-2 adrenergic agonists, if bronchospasm develops. Consider systemic corticosteroids in patients with significant bronchospasm (National Heart,Lung,and Blood Institute, 2007). Exposed skin and eyes should be flushed with copious amounts of water.
    6.7.2) TREATMENT
    A) AIRWAY MANAGEMENT
    1) INTUBATION (preferred method) OR TRACHEOTOMY may be life-saving following severe exposure (Close et al, 1980; Millea et al, 1989).
    B) MONITORING OF PATIENT
    1) Monitor patient for respiratory distress. If a cough or difficulty in breathing develops, evaluate for respiratory tract irritation, bronchitis, and pneumonia.
    C) ACUTE LUNG INJURY
    1) ONSET: Onset of acute lung injury after toxic exposure may be delayed up to 24 to 72 hours after exposure in some cases.
    2) NON-PHARMACOLOGIC TREATMENT: The treatment of acute lung injury is primarily supportive (Cataletto, 2012). Maintain adequate ventilation and oxygenation with frequent monitoring of arterial blood gases and/or pulse oximetry. If a high FIO2 is required to maintain adequate oxygenation, mechanical ventilation and positive-end-expiratory pressure (PEEP) may be required; ventilation with small tidal volumes (6 mL/kg) is preferred if ARDS develops (Haas, 2011; Stolbach & Hoffman, 2011).
    a) To minimize barotrauma and other complications, use the lowest amount of PEEP possible while maintaining adequate oxygenation. Use of smaller tidal volumes (6 mL/kg) and lower plateau pressures (30 cm water or less) has been associated with decreased mortality and more rapid weaning from mechanical ventilation in patients with ARDS (Brower et al, 2000). More treatment information may be obtained from ARDS Clinical Network website, NIH NHLBI ARDS Clinical Network Mechanical Ventilation Protocol Summary, http://www.ardsnet.org/node/77791 (NHLBI ARDS Network, 2008)
    3) FLUIDS: Crystalloid solutions must be administered judiciously. Pulmonary artery monitoring may help. In general the pulmonary artery wedge pressure should be kept relatively low while still maintaining adequate cardiac output, blood pressure and urine output (Stolbach & Hoffman, 2011).
    4) ANTIBIOTICS: Indicated only when there is evidence of infection (Artigas et al, 1998).
    5) EXPERIMENTAL THERAPY: Partial liquid ventilation has shown promise in preliminary studies (Kollef & Schuster, 1995).
    6) CALFACTANT: In a multicenter, randomized, blinded trial, endotracheal instillation of 2 doses of 80 mL/m(2) calfactant (35 mg/mL of phospholipid suspension in saline) in infants, children, and adolescents with acute lung injury resulted in acute improvement in oxygenation and lower mortality; however, no significant decrease in the course of respiratory failure measured by duration of ventilator therapy, intensive care unit, or hospital stay was noted. Adverse effects (transient hypoxia and hypotension) were more frequent in calfactant patients, but these effects were mild and did not require withdrawal from the study (Wilson et al, 2005).
    7) However, in a multicenter, randomized, controlled, and masked trial, endotracheal instillation of up to 3 doses of calfactant (30 mg) in adults only with acute lung injury/ARDS due to direct lung injury was not associated with improved oxygenation and longer term benefits compared to the placebo group. It was also associated with significant increases in hypoxia and hypotension (Willson et al, 2015).
    D) BRONCHOSPASM
    1) Aminophylline or nebulized bronchodilators may be useful in patients with bronchospasm (Flury et al, 1983).
    E) CORTICOSTEROID
    1) Although corticosteroids have been used to treat ammonia inhalation injury, they have not been shown to decrease mortality (Price et al, 1983; Welch et al, 1977) and may increase mortality (Flury et al, 1983; Lucas & Ledgerwood, 1981). Steroids may be indicated in severe bronchospasm unresponsive to other therapies (Arwood et al, 1985).
    2) In a placebo-controlled study of ammonia-induced lung injury in a rabbit model, treatment with inhaled budesonide did not improve gas exchange or reduce airway pressure levels (Sjoblom et al, 1999).
    F) ANTIBIOTIC
    1) The use of prophylactic antibiotics resulted in infection with resistant organisms in 7 of 29 cases (Close et al, 1980; Flury et al, 1983; Levy et al, 1964; O'Kane, 1983; Pontoppidan et al, 1972).
    G) Treatment should include recommendations listed in the ORAL EXPOSURE section when appropriate.

Eye Exposure

    6.8.1) DECONTAMINATION
    A) Immediate irrigation is essential. Exposed eyes should be irrigated with copious amounts of tepid water for at least 20 to 30 minutes (Grant, 1993; Beare et al, 1988). Irrigate until the pH of the conjunctival sac is less than 8.5. If irritation, pain, swelling, lacrimation, or photophobia persist after 15 minutes of irrigation, an ophthalmologic examination is recommended.
    6.8.2) TREATMENT
    A) INJURY OF GLOBE OF EYE
    1) EVALUATION
    a) Corneal fluorescein staining and slit lamp examination are highly recommended after splash contact with household ammonia.
    2) MINOR INJURY
    a) Topical antibiotics for minor damage and topical steroids for more serious epithelial damage may be required (Beare et al, 1988).
    3) SEVERE INJURY
    a) Cycloplegic or mydriatic agents may decrease the discomfort and help to prevent synechiae (Millea et al, 1989).
    b) Topical steroids may be useful to reduce the inflammation (Levy et al, 1964).
    B) RAISED INTRAOCULAR PRESSURE
    1) Acetazolamide may be of value in reducing intraocular pressure (Highman, 1969).
    C) Treatment should include recommendations listed in the ORAL EXPOSURE section when appropriate.

Dermal Exposure

    6.9.1) DECONTAMINATION
    A) DERMAL DECONTAMINATION
    1) DECONTAMINATION: Remove contaminated clothing and wash exposed area thoroughly with soap and water for 10 to 15 minutes. A physician may need to examine the area if irritation or pain persists (Burgess et al, 1999).
    6.9.2) TREATMENT
    A) FROSTBITE
    1) Pressurized liquid ammonia has a temperature of minus 33 degrees C.
    2) PREHOSPITAL
    a) Rewarming of a localized area should only be considered if the risk of refreezing is unlikely. Avoid rubbing the frozen area which may cause further damage to the area (Grieve et al, 2011; Hallam et al, 2010).
    3) REWARMING
    a) Do not institute rewarming unless complete rewarming can be assured; refreezing thawed tissue increases tissue damage. Place affected area in a water bath with a temperature of 40 to 42 degrees Celsius for 15 to 30 minutes until thawing is complete. The bath should be large enough to permit complete immersion of the injured part, avoiding contact with the sides of the bath. A whirlpool bath would be ideal. Some authors suggest a mild antibacterial (ie, chlorhexidine, hexachlorophene or povidone-iodine) be added to the bath water. Tissues should be thoroughly rewarmed and pliable; the skin will appear a red-purple color (Grieve et al, 2011; Hallam et al, 2010; Murphy et al, 2000).
    b) Correct systemic hypothermia which can cause cold diuresis due to suppression of antidiuretic hormone; consider IV fluids (Grieve et al, 2011).
    c) Rewarming may be associated with increasing acute pain, requiring narcotic analgesics.
    d) For severe frostbite, clinical trials have shown that pentoxifylline, a phosphodiesterase inhibitor, can enhance tissue viability by increasing blood flow and reducing platelet activity (Hallam et al, 2010).
    4) WOUND CARE
    a) Digits should be separated by sterile absorbent cotton; no constrictive dressings should be used. Protective dressings should be changed twice per day.
    b) Perform twice daily hydrotherapy for 30 to 45 minutes in warm water at 40 degrees Celsius. This helps debride devitalized tissue and maintain range of motion. Keep the area warm and dry between treatments (Hallam et al, 2010; Murphy et al, 2000).
    c) The injured extremities should be elevated and should not be allowed to bear weight.
    d) In patients at risk for infection of necrotic tissue, prophylactic antibiotics and tetanus toxoid have been recommended by some authors (Hallam et al, 2010; Murphy et al, 2000).
    e) Non-tense clear blisters should be left intact due to the risk of infection; tense or hemorrhagic blisters may be carefully aspirated in a setting where aseptic technique is provided (Hallam et al, 2010).
    f) Further surgical debridement should be delayed until mummification demarcation has occurred (60 to 90 days). Spontaneous amputation may occur.
    g) Analgesics may be required during the rewarming phase; however, patients with severe pain should be evaluated for vasospasm.
    h) IMAGING: Arteriography and noninvasive vascular techniques (e.g., plain radiography, laser Doppler studies, digital plethysmography, infrared thermography, isotope scanning), have been useful in evaluating the extent of vasospasm after thawing and assessing whether debridement is needed (Hallam et al, 2010). In cases of severe frostbite, Technetium 99 (triple phase scanning) and MRI angiography have been shown to be the most useful to assess injury and determine the extent or need for surgical debridement (Hallam et al, 2010).
    i) TOPICAL THERAPY: Topical aloe vera may decrease tissue destruction and should be applied every 6 hours (Murphy et al, 2000).
    j) IBUPROFEN THERAPY: Ibuprofen, a thromboxane inhibitor, may help limit inflammatory damage and reduce tissue loss (Grieve et al, 2011; Murphy et al, 2000). DOSE: 400 mg orally every 12 hours is recommended (Hallam et al, 2010).
    k) THROMBOLYTIC THERAPY: Thrombolysis (intra-arterial or intravenous thrombolytic agents) may be beneficial in those patients at risk to lose a digit or a limb, if done within the first 24 hours of exposure. The use of tissue plasminogen activator (t-PA) to clear microvascular thromboses can restore arterial blood flow, but should be accompanied by close monitoring including angiography or technetium scanning to evaluate the injury and to evaluate the effects of t-PA administration. Potential risk of the procedure includes significant tissue edema that can lead to a rise in interstitial pressures resulting in compartment syndrome (Grieve et al, 2011).
    l) CONTROVERSIAL: Adjunct pharmacological agents (ie, heparin, vasodilators, prostacyclins, prostaglandin synthetase inhibitors, dextran) are controversial and not routinely recommended. The role of hyperbaric oxygen therapy, sympathectomy remains unclear (Grieve et al, 2011).
    m) CHRONIC PAIN: Vasomotor dysfunction can produce chronic pain. Amitriptyline has been used in some patients; some patients may need a referral for pain management. Inability to tolerate the cold (in the affected area) has been observed following a single episode of frostbite (Hallam et al, 2010).
    n) MORBIDITIES: Frostbite can produce localized osteoporosis and possible bone loss following a severe case. These events may take a year or more to develop. Children may be at greater risk to develop more severe events (ie, early arthritis) (Hallam et al, 2010).
    B) WOUND CARE
    1) Debride nonviable tissue (Millea et al, 1989).
    2) Excision and closure or skin grafting may be necessary for small full-thickness tissue injuries (Millea et al, 1989).
    3) Daily debridement and dressing changes, usually with silver sulfadiazine 1 percent may be of benefit for partial-thickness burns (Millea et al, 1989).
    4) Appropriate measures should be taken to prevent wound infection and sepsis in these patients (Millea et al, 1989).
    C) Treatment should include recommendations listed in the ORAL EXPOSURE section when appropriate.

Case Reports

    A) SPECIFIC AGENT
    1) ANHYDROUS AMMONIA: Yang et al (1987) reported 22 workers exposed to anhydrous ammonia when a container exploded in an enclosed area of a seafood processing plant. Duration of exposure lasted from a few seconds to twenty minutes (Yang et al, 1987).
    a) Fourteen patients with mild exposure developed mild irritant effects only. Six patients had moderate symptoms, with transient lip and oral mucosal edema and bronchospasm. Two patients were severely affected, with coma and either respiratory failure or dermal burns. One of them died due to respiratory failure after two weeks, and the second developed chronic bronchitis and restrictive pulmonary disease which was still present at 6 month follow-up.
    b) The authors noted that the severity of illness correlated well with the ammonia air concentration and duration of exposure.
    2) GASEOUS AMMONIA: Montague & Macneil (1980) reported a case of 14 fishermen who were acutely exposed, while sleeping, to a massive gaseous ammonia leak in the ship's refrigeration system. Exposure durations ranged from a few seconds to several minutes (Montague & Macneil, 1980).
    a) All patients developed significant respiratory distress upon awakening and complained of pharyngeal pain, pleuritic chest pain, cough, or dyspnea. Six patients developed eye symptoms. Two patients had persistent respiratory complications. One patient required tracheostomy to relieve stridor secondary to laryngeal edema. The second patient with persistent airway obstruction also required tracheostomy.
    b) The authors observed that the best prediction of the future clinical course in this group of patients was the presence or absence of abnormal chest findings at admission.
    3) HOUSEHOLD AMMONIA: Three adults developed esophageal burns after suicidal ingestion of household ammonia containing 3% to 3.6% ammonia at a pH of 11.5 to 11.8 (Klein et al, 1985).
    4) HOUSEHOLD AMMONIA: A 15-year-old who ingested 30 mL developed esophageal burns with no perforations.
    5) HOUSEHOLD AMMONIA: A middle-aged woman ingested two "gulps" and developed mild to moderate esophageal ulceration and bleeding.
    6) HOUSEHOLD AMMONIA: An unusually symptomatic case following household ammonia ingestion involved a 69-year-old who ingested an unknown amount and developed aspiration pneumonia, severe corrosive esophageal injury, and died of ARDS and renal failure.
    7) AROMATIC AMMONIA: In a series of fifteen cases of oral exposure to aromatic ammonia solution, adverse effects were not serious.
    a) Exposures occurred when an ammonia inhalant capsule was broken between the teeth, releasing the solution into the oral cavity. All patients showed symptoms of discomfort and oral burns and/or cuts. Other common symptoms were drooling and swelling of the lips.
    b) All patients were treated with dilution; in eleven, no additional treatment was necessary. Esophagoscopy was performed in 2 patients; the esophagus was normal in one patient, and the other showed minimal irritation. Fourteen patients showed resolution of symptoms within 3 days; one patient was lost to follow-up.
    c) Although the solution has an alkaline pH, the small volume (0.33 to 0.44 mL) suggests that esophageal damage is unlikely. Oral exposure to aromatic ammonia solution from ammonia inhalants can probably be managed conservatively with dilution and without esophagoscopy (Wallace, 1989).

Summary

    A) Serious burns less likely if pH <11.5. Injury greater with either large ingestion (usually deliberate) or high concentration ammonia (usually not household products which typically contain 5% to 10% ammonia).
    B) With highly concentrated liquids (27% to 30% industrial strength ammonia), esophageal burns may occur in up to 100% of patients, even after accidental ingestion.

Minimum Lethal Exposure

    A) CASE REPORTS
    1) HOUSEHOLD AMMONIA - A 69-year-old woman who ingested an unknown amount of household ammonia (3%) developed aspiration pneumonia, corrosive esophageal injury, ARDS, and renal failure, and died several days after admission (Klein et al, 1985).
    2) A worker died one month after exposure to an unknown amount of ammonia gas emitted from a ruptured pipe. Autopsy revealed acute laryngitis, tracheitis, bronchopneumonia, and pulmonary edema. The kidneys were congested and showed signs of hemorrhagic nephritis (HSDB, 2005).
    B) ROUTE OF EXPOSURE
    1) AIRBORNE AMMONIA
    a) Fatalities may occur from exposure to ammonia concentrations of 2500 to 4500 parts per million for 30 minutes (ATSDR, 2004; Millea et al, 1989; Helmers et al, 1971).
    b) Rapid respiratory arrest may occur at ammonia concentrations above 5000 parts per million (Millea et al, 1989; Helmers et al, 1971).
    c) Immediate death may occur from laryngeal spasm, inflammation, or edema with exposure to 5000 ppm (CHRIS, 2005).
    d) Inhalation exposure to concentrations of 2500 to 6500 ppm may lead to fatal pulmonary edema, dyspnea, or upper airway obstruction (Hathaway et al, 1996).
    e) Acute exposure to concentrations of 5,000 to 10,000 ppm are reportedly lethal (HSDB, 2005).
    C) ANIMAL DATA
    1) A 50 percent mortality rate resulted from exposure of cats and rabbits to ammonia for 1 hour at 7000 mg/m(3); the respiratory tract was severely affected in these animals (Clayton & Clayton, 1993).
    2) Of the 51 rats exposed to 455 mg/m(3) of ammonia each day for 65 days, 32 died by day 25; 18 more died by day 65 (Clayton & Clayton, 1993).
    3) When various animal species were exposed to 470 mg/m(3) of ammonia continuously for 90 days, this resulted in the death of 13/15 rats, 4/15 guinea pigs, 0/3 rabbits, 0/2 beagles, and 0/3 squirrel monkeys (Clayton & Clayton, 1993).

Maximum Tolerated Exposure

    A) GENERAL/SUMMARY
    1) Physiological reactions to ammonia (Finkel, 1983) -
     Concentration (ppm)
    Detectable odor53
    Amount causing immediate irritation to the eye698
    Amount causing immediate throat irritation408
    Amount causing coughing1720
    Maximum concentration allowable for prolonged exposure100
    Maximum concentration allowable for 1/2 to 1 hour300-500
    Dangerous for short exposure (1/2 hour)2500-4500
    Rapidly fatal for short exposure5000-10,000

    2) As with most caustic solutions, the concentration is more critical than the volume in determining whether or not burns will develop.
    B) CONCENTRATION LEVEL
    1) POSSIBLE RELATED HEALTH EFFECTS
    a) Exposures to ammonia levels exceeding 30 ppm result in immediate irritation to the nose and throat (ATSDR, 2004).
    b) Household ammonia (5 to 10 percent) rarely causes tissue burns, although esophageal burns with laryngeal and epiglottic edema have been reported (Klein et al, 1985). Commercial ammonia for industrial use (27 to 30 percent) is more caustic and likely to cause burns of the eye, esophagus, and skin.
    c) An airborne ammonia concentration of 100 parts per million is tolerable for several hours (Millea et al, 1989).
    d) Minor irritation of mucosal surfaces and the eyes may occur at ammonia concentrations of 400 to 450 parts per million (Millea et al, 1989).
    e) Eye injuries have been reported at an ammonia concentration of 700 parts per million (Millea et al, 1989).
    f) Ammonia concentration of 1700 parts per million may result in coughing and laryngospasm, with edema of the glottic region developing within a few hours (Millea et al, 1989).
    g) Eight of 16 individuals exposed to 140 ppm of ammonia for 2 hours terminated the exposure prematurely due to severe irritation (Clayton & Clayton, 1993).
    h) Inhalation of and exposure to 2500 to 6500 ppm of ammonia causes serious corneal irritation, dyspnea, bronchospasm, chest pain, and pulmonary edema. Following massive doses, chronic airway hyperreactivity and asthma, with related obstructive pulmonary function changes have been documented (Hathaway et al, 1996).
    i) Aromatic Ammonia - Oropharyngeal burns have been reported in children who bite into aromatic ammonia capsules (smelling salts). There are no reports of esophageal burns (Lopez et al, 1988; Wason et al, 1990).
    j) The maximum limit as stated in the Submarine Atmosphere Habitability Data Book, published by the US Navy, for continuous exposures in submarines is 25 parts per million (ACGIH, 1991).
    k) Potential health effects associated with anhydrous ammonia include: burns, lung damage, blindness, and death (NIOSH, 2005).

Workplace Standards

    A) ACGIH TLV Values for CAS7664-41-7 (American Conference of Governmental Industrial Hygienists, 2010):
    1) Editor's Note: The listed values are recommendations or guidelines developed by ACGIH(R) to assist in the control of health hazards. They should only be used, interpreted and applied by individuals trained in industrial hygiene. Before applying these values, it is imperative to read the introduction to each section in the current TLVs(R) and BEI(R) Book and become familiar with the constraints and limitations to their use. Always consult the Documentation of the TLVs(R) and BEIs(R) before applying these recommendations and guidelines.
    a) Adopted Value
    1) Ammonia
    a) TLV:
    1) TLV-TWA: 25 ppm
    2) TLV-STEL: 35 ppm
    3) TLV-Ceiling:
    b) Notations and Endnotes:
    1) Carcinogenicity Category: Not Listed
    2) Codes: Not Listed
    3) Definitions: Not Listed
    c) TLV Basis - Critical Effect(s): Eye dam; URT irr
    d) Molecular Weight: 17.03
    1) For gases and vapors, to convert the TLV from ppm to mg/m(3):
    a) [(TLV in ppm)(gram molecular weight of substance)]/24.45
    2) For gases and vapors, to convert the TLV from mg/m(3) to ppm:
    a) [(TLV in mg/m(3))(24.45)]/gram molecular weight of substance
    e) Additional information:

    B) NIOSH REL and IDLH Values for CAS7664-41-7 (National Institute for Occupational Safety and Health, 2007):
    1) Listed as: Ammonia
    2) REL:
    a) TWA: 25 ppm (18 mg/m(3))
    b) STEL: 35 ppm (27 mg/m(3))
    c) Ceiling:
    d) Carcinogen Listing: (Not Listed) Not Listed
    e) Skin Designation: Not Listed
    f) Note(s):
    3) IDLH:
    a) IDLH: 300 ppm
    b) Note(s): Not Listed

    C) Carcinogenicity Ratings for CAS7664-41-7 :
    1) ACGIH (American Conference of Governmental Industrial Hygienists, 2010): Not Listed ; Listed as: Ammonia
    2) EPA (U.S. Environmental Protection Agency, 2011): Not Assessed under the IRIS program. ; Listed as: Ammonia
    3) IARC (International Agency for Research on Cancer (IARC), 2016; International Agency for Research on Cancer, 2015; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010a; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2008; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2006; IARC, 2004): Not Listed
    4) NIOSH (National Institute for Occupational Safety and Health, 2007): Not Listed ; Listed as: Ammonia
    5) MAK (DFG, 2002): Not Listed
    6) NTP (U.S. Department of Health and Human Services, Public Health Service, National Toxicology Project ): Not Listed

    D) OSHA PEL Values for CAS7664-41-7 (U.S. Occupational Safety, and Health Administration (OSHA), 2010):
    1) Listed as: Ammonia
    2) Table Z-1 for Ammonia:
    a) 8-hour TWA:
    1) ppm: 50
    a) Parts of vapor or gas per million parts of contaminated air by volume at 25 degrees C and 760 torr.
    2) mg/m3: 35
    a) Milligrams of substances per cubic meter of air. When entry is in this column only, the value is exact; when listed with a ppm entry, it is approximate.
    3) Ceiling Value:
    4) Skin Designation: No
    5) Notation(s): Not Listed

Toxicity Information

    7.7.1) TOXICITY VALUES
    A) TCLo- (INHALATION)MOUSE:
    1) 10 mg/m(3) for 2H -- blood changes, cholinesterase and other oxidoreductases (RTECS, 2005)
    2) 30 mg/m(3) for 2H (RTECS, 2005)
    B) TCLo- (INHALATION)RAT:
    1) 350 mg/m(3) for 4H -- cough (RTECS, 2005)
    2) 25 mg/m(3) for 4H -- dyspnea (RTECS, 2005)
    C) References: ITI, 1995; Lewis, 1992; Lewis, 2000; RTECS, 2005.
    1) LD50- (INHALATION)MOUSE:
    a) 4837 ppm for 1H (Lewis, 2000a)
    2) LD50- (ORAL)RAT:
    a) 350 mg/kg (Lewis, 1992a)
    3) LD50- (SKIN)RAT:
    a) 112,000 mg/m(3) for 15M (RTECS, 2005)
    b) 71,900 mg/m(3) for 30M (RTECS, 2005)
    c) 4840 mg/m(3) for 60M (RTECS, 2005)
    4) TCLo- (INHALATION)HUMAN:
    a) 20 ppm -- ulcerated nasal septum, conjunctive irritation, change in trachea or bronchi (RTECS, 2005)
    b) 40 mg/m(3) -- conjunctive irritation, cough, respiratory depression (RTECS, 2005)
    c) 3 mg/m(3) for 8H -- change in heart rate, respiratory depression (RTECS, 2005)
    d) 1200 mg/m(3) -- acute pulmonary edema, cough, dyspnea (RTECS, 2005)
    5) TCLo- (SKIN)HUMAN:
    a) 1000 mg/kg (ITI, 1995)

Pharmacologic Mechanism

    A) In the cat, ammonia decreases postsynaptic inhibition of cortical, spinal and trochlear motor neurons (Haliburton et al, 1989).

Toxicologic Mechanism

    A) Ammonia acts as an alkali. Concentrated exposure may result in mucosal burns secondary to liquefaction necrosis. The burns generally feel soapy as a result of saponification of the tissue fat. The damage produced by topical exposure to esophagus, eye, and skin is similar to that seen with other alkaline caustics. Due to its volatility, inhalation of mild-moderate ammonia vapors may result in irritation of the respiratory passages or may produce pneumonitis or pulmonary edema.

Physical Characteristics

    A) Ammonia is a colorless gas with a very pungent odor (characteristic of drying urine) (HSDB, 2005; Budavari, 1996).
    B) The odor threshold can be detected in the range of 5 to 50 ppm ((ASTI, 1999)).
    C) Ammonia is a colorless, lighter-than-air gas with a characteristic extremely penetrating, pungent, intensely irritating, suffocating odor (NIOSH, 2005; AAR, 2000; Lewis, 1997; Budavari, 1996).
    D) Ammonia floats on and boils on water, producing a visible and poisonous vapor cloud (CHRIS, 2005).
    E) Ammonia is available in a commercial grade of 99.5% purity and a refrigerant grade of 99.97% purity (Lewis, 1997).
    F) Aromatic spirits of ammonia ampules contain 0.33 mL of 15% ammonia hydroxide and 35% alcohol, although formulations for aromatic spirits may vary (Wallace, 1989; Wason et al, 1990).
    G) Ammonia is a toxic gas under ambient conditions ((ASTI, 1999)).

Ph

    A) 11.6 (1.0 N aqueous solution) (HSDB, 2005; Budavari, 1996)
    B) 11.1 (0.1 N aqueous solution) (HSDB, 2005; Budavari, 1996)
    C) 10.6 (0.01 N aqueous solution) (HSDB, 2005; Budavari, 1996)

Molecular Weight

    A) 17.04

Other

    A) ODOR THRESHOLD
    1) 46.8 ppm (CHRIS, 2005)

Clinical Effects

    11.1.1) AVIAN/BIRD
    A) Signs are seen from gaseous ammonia when birds are exposed to 75 to 100 ppm or more. Chickens on deep litter may exhibit keratoconjunctivitis, corneal opacity and tracheitis. They may keep their eyes closed, become listless and anorexic (Beasley et al, 1989).
    B) Ammonium sulphate has been shown to cause a reduced weight gain and feed conversion in experimental chicks (Humphreys, 1988).
    11.1.2) BOVINE/CATTLE
    A) A general rule of thumb is that NPN should not comprise more than one-third of the total nitrogen in the ration. High rumen pH, high body temperature, restricted water intake, and liver disease will lessen the amount of NPN needed to produce toxicosis (Howard, 1986).
    B) Exposure of calves to 50 or 100 ppm ammonia causes an increase in the frequency of change in the depth of respiration (Humphreys, 1988).
    C) Heifers consuming ammoniated grass silage developed hyperesthetic, hyperactive symptoms and massive salivation. Signs did not reoccur if hay was fed one day after aeration. Hay contained 9 g ammonia per kg fresh weight (Kamphues, 1991).
    D) Signs of poisoning with ammonium sulphate include severe colic, groaning, shivering, staggering, forced rapid breathing, a very marked jugular pulse, and death after violent struggling and bellowing (Humphreys, 1988).
    11.1.3) CANINE/DOG
    A) Intravenous administration of ammonium acetate induces hyperammonemia and respiratory alkalosis in dogs (Kirk, 1986).
    B) Hyperammonemia as a result of an enzyme deficiency in the urea cycle (e.g. arginosuccinate synthetase) has been reported in dogs.
    11.1.4) CAPRINE/GOAT
    A) Fatal intoxication from urea has been reported (Humphreys, 1988).
    B) Goats and cattle have similar clinical signs including salivation, restlessness, dyspnea, collapse, violent attempts to kick the stomach, muscular spasms, and bloat (Humphreys, 1988).
    11.1.5) EQUINE/HORSE
    A) Administration of 450 g of urea, which caused the death of seven of eight ponies, resulted in an increase in blood urea, ammonia, alpha-ketoglutarate, glucose, and pyruvate concentrations (Humphreys, 1988).
    11.1.6) FELINE/CAT
    A) Ammonia Tolerance Test (ATT): Inability to regulate blood ammonia is best assessed by the ATT (Kirk, 1989).
    B) Experimentally induced arginine deficiency has resulted in feline hepatic encephalopathy. Since arginine is an essential component of the urea cycle, its absence results in decreased ammonia detoxification.
    11.1.9) OVINE/SHEEP
    A) Urea poisoning in sheep is associated with elevated blood ammonia concentration, increased erythrocyte counts and PCV values, and decreased leucocyte counts.
    B) The blood ammonia concentration of the fetus of fatally-poisoned sheep is lower than that of the dam at death. The ammonia concentrations differ between dam and fetus in the liver, kidneys, spleen, and muscles also (Humphreys, 1988).
    C) Urea poisoning has been reported in sheep which drank a 21% solution used as fertilizer for cotton, and consumed treated rations (Humphreys, 1988).
    11.1.10) PORCINE/SWINE
    A) Administration of ammonium carbonate to pigs causes vomiting, hyperventilation, hypersensitivity to sound and tetany, followed by death in some animals (Humphreys, 1988).
    B) An increase in secondary respiratory infections including an increase in severity of atrophic rhinitis may occur in gaseous ammonia exposed animals (Beasley et al, 1989).
    11.1.13) OTHER
    A) OTHER
    1) GENERAL -
    a) All mammalian species are susceptible to ammonia poisoning, and have similar susceptibility to poisoning by ammonium salts.
    2) RUMINANTS -
    a) Ruminants are more susceptible to ammonia toxicosis from urea than other forms of NPN because the rumen contains the urolytic enzyme urease. The enzyme catalyzes the hydrolysis of urea, hastening the liberation of ammonia (Haliburton et al, 1989).
    b) Non-protein-nitrogen toxicosis usually results from improper mixing of NPN into feed; error in calculations or formulations of rations; inadequate period of adaptation to NPN; NPN rations deficient in energy, low in protein and high in fiber; and unrestricted consumption of liquid NPN supplements (Haliburton et al, 1989).
    c) Within 10 minutes to 4 hours following the ingestion of excess urea or other NPN sources, animals may exhibit frothy salivation, depression, hyperirritability, grinding of teeth, abdominal pain, increased defecation, and polyuria. Animals may appear blind. Muscle tremors, incoordination, increased respiratory rate and general weakness are commonly seen (Beasley et al, 1989).
    d) Ruminants may show signs of mild toxicosis following ingestion of 0.3 to 0.5 gram of urea or ammonium salts/kg body weight (Beasley et al, 1989).
    e) Signs appear when rumen ammonia and blood ammonia concentrations exceed 80 mg/100 mL and 2 mg/100 mL, respectively. Bloat and regurgitation of rumen contents may occur especially in sheep. Recumbency, hyperthermia, cyanosis, anuria and seizures are common terminal signs (Beasley et al, 1989).
    f) The pathological changes associated with ammonium or ammonium salt poisoning include: pulmonary edema; large hemorrhagic patches on the mucous membranes of the stomach and intestines; edema and ulceration of the intestinal mucous membranes; enlarged, pale, friable liver; petechiae in the skin; hemorrhages on the surfaces of kidneys and epicardium; and degenerative changes in the central nervous system (Humphreys, 1988).
    g) Some predisposing factors for ammonia toxicosis in ruminants include: fasting; high roughage diets; lack of adaptation to high NPN diets; high ruminal pH; high rumen and body temperature; dehydration or low water intake; and hepatic insufficiency (Osweiler et al, 1985).
    h) The ruminant needs as much as several days to adapt fully to incorporation of additional ammonia into microbial protein (Osweiler et al, 1985).
    3) MONOGASTRIC -
    a) Monogastric animals, such as the pig and baby calf, are unaffected by oral ingestion of urea except for a transient diuretic action (Osweiler et al, 1985).

Treatment

    11.2.1) SUMMARY
    A) GENERAL TREATMENT
    1) Treatment is only effective if given within 20 to 30 minutes after the appearance of clinical signs. Recumbent animals almost never respond. Treatment should involve the use of weak acid as a chemical antidote, demulcents, and stimulants.
    11.2.2) LIFE SUPPORT
    A) GENERAL
    1) MAINTAIN VITAL FUNCTIONS: Secure airway, supply oxygen, and begin supportive fluid therapy if necessary.
    11.2.5) TREATMENT
    A) CATTLE
    1) ACETIC ACID - The best treatment for cattle consists of administration of a combination of 5 to 10 gallons of cold water and a gallon of 5 percent acetic acid (or vinegar) by means of a stomach tube. The cold water reduces the temperature of the rumen and thus the rate of urease action. The acetic acid reduces the rumen pH (also slows urease activity) and converts the readily absorbed ammonia present in ruminal fluids to the relative innocuous ammonium ion. When performed on non-recumbent animals showing tetany, recovery with return of normal rumen pH and fermentation occurs within 48 hours. Retreatment is usually not required.
    a) Administration of 1 mole of acetic acid per mole of urea at 15 minutes, and 1 mole per mole 180 minutes after giving 0.44 gram/kilograms body weight of urea resulted in the survival of 28 of 29 pregnant cows (Humphreys, 1988).
    b) LAVAGE - Rumen lavage via a rumenotomy incision or trochar is believed by some to be superior to cold water and acetic acid (Beasley et al, 1989).
    2) FLUIDS - Intravenous fluids should be administered to insure adequate urine flow. Maintenance dose of intravenous isotonic fluids for calves and debilitated adult cattle: 140 milliliters/kilogram/day. Dose for rehydration: 50 to 100 milliliters/kilogram given over 4 to 6 hours.
    3) If bloat occurs, it should be relieved immediately.

Range Of Toxicity

    11.3.1) THERAPEUTIC DOSE
    A) RUMINANT
    1) Urea generally has been recommended at a maximum rate of approximately 3% of the grain ration or 1% of the total ration (Haliburton et al, 1989).
    2) One part of urea is equivalent to 2.92 parts of protein and 1% protein is equivalent to 0.34% urea (Beasley et al, 1989).
    3) SHEEP: The short term feeding of protein concentrates before giving urea supplements can increase sheep's tolerance to urea (Humphreys, 1988).
    B) SWINE
    1) Single doses of 16 g/kg body weight and 10% of urea in the feed had no effect on two-week-old piglets. Incorporation of 0.4, 0.6 or 1 g of urea per kg body weight into the ration of 18-month-old pigs failed to produce intoxication, although the highest level made the feed unpalatable (Humphreys, 1988).
    2) INHALATION - Recommended maximal concentrations of ammonia in swine housing air environments was 7 ppm (Donham, 1991).
    C) HORSE
    1) The normal range of ammonia found in equine serum is 13 to 108 micrograms/deciliter (Smith, 1990).
    11.3.2) MINIMAL TOXIC DOSE
    A) RUMINANT
    1) TOLERANCE - In cattle unaccustomed to urea the toxic dose is approximately 0.45 gram urea/kilogram body weight. In cattle accustomed to urea, the lethal dose is 1 to 1.5 gram urea per kilogram body weight and ammonium salts may be lethal at 1 to 2 grams/kilogram body weight. Biuret has the greatest degree of safety with a lethal dose of 8 grams per kilogram body weight (Haliburton et al, 1989).
    a) As little as 50 grams can cause poisoning in cattle not accustomed to it. Slowly increasing the urea content of the feed can allow bullocks to tolerate as much as 400 grams/day without ill effects (Humphreys, 1988).
    2) CALCULATIONS - To calculate a toxic dose, urea and ammonium salts can be considered together, as in the examples below.
    a) Feed tag states that the feed contains 70% crude protein with 10% from soybean meal and the remaining 60% as protein equivalent from NPN sources. 60% x 0.34 = 20.4% urea content.
    b) One kilogram would contain 204 grams urea -- enough to poison a 200 to 400 kilogram animal if rapidly ingested (Beasley et al, 1989).
    3) TOXIC BLOOD/SERUM LEVELS - Muscular twitches are associated with a blood ammonia nitrogen concentration of 9.3 micrograms/milliliter. In cattle given fatal doses of urea, blood ammonia nitrogen concentrations between 19.5 and 27 micrograms/milliliter preceded death. The maximum capacity of the liver to remove ammonia is 1.84 millimoles/kilogram wet weight in adult cows. Arterial plasma ammonia concentration of 0.8 millimoles causes intoxication (Humphreys, 1988).
    4) CATTLE/SHEEP - Doses of 0.5 to 1.5 grams/kilogram of urea, urea phosphate, and ammonium salts may be lethal to cattle and sheep (Beasley et al, 1989).
    5) SHEEP - Experimental administration of 0.5 kilogram of urea has been shown to cause intoxication of the heaviest, while 0.8 gram/kilogram resulted in poisoning of all treated sheep (Humphreys, 1988).
    6) FARM ANIMALS - All farm animals are susceptible to poisoning by ammonium salts, with doses of 0.3 to 0.5 gram/kilogram usually causing clinical signs and doses of 0.5 to 1.5 grams/kilogram being the minimum lethal dose (MLD).
    7) ATMOSPHERIC - A maximum permissible level of 35 ppm is recommended for atmospheric ammonia levels in calf houses (Humphreys, 1988).
    B) MONOGASTRICS -
    1) Ingestion of 1.5 grams/kilogram of ammonium salts are lethal to monogastric animals (Beasley et al, 1989).
    2) HORSE
    a) Horses are of intermediate susceptibility to poisoning by urea. Doses of 4 grams/kilogram of urea and 1.4 grams/kilogram of ammonium salts may cause death (Beasley et al, 1989).
    b) Ammonia toxicosis was produced in ponies by feeding one pound of urea (Robinson, 1987).
    c) Minimum lethal dose is greater than or equal to 4 grams/kilogram (Howard, 1986).
    3) POULTRY
    a) The concentration of ammonia in the atmosphere in poultry houses should not exceed 30 parts per million (Humphreys, 1988).

Continuing Care

    11.4.1) SUMMARY
    11.4.1.2) DECONTAMINATION/TREATMENT
    A) GENERAL TREATMENT
    1) Treatment is only effective if given within 20 to 30 minutes after the appearance of clinical signs. Recumbent animals almost never respond. Treatment should involve the use of weak acid as a chemical antidote, demulcents, and stimulants.
    11.4.3) TREATMENT
    11.4.3.5) SUPPORTIVE CARE
    A) GENERAL
    1) Ongoing treatment is symptomatic and supportive.
    11.4.3.6) OTHER
    A) OTHER
    1) GENERAL
    a) LABORATORY/PREMORTEM -
    1) The most specific laboratory test available to confirm that neurologic signs are attributable to hepatic encephalopathy is determination of blood ammonia concentration (Kirk, 1986).
    2) Three milliliters of heparinized plasma, frozen immediately, is needed to test for blood ammonia (Kirk & Bistner, 1985).
    3) Abnormalities in blood ammonia levels can be seen in the hepatoencephalopathy conditions, most common of which is a congenital portalcaval shunt. Acquired diseases such as cirrhosis, toxic hepatopathy and hepatic neoplasia can also lead to this condition.
    4) AMMONIA TOLERANCE TEST - This test can be done in the dog and cat by administering NH4CL after a fast. Normal levels are usually 19 to 120 milligrams per deciliter in the dog, with levels above 300 abnormal. Blood ammonia levels for the cat following oral administration of 100 milligrams per kilogram of ammonium chloride have been reported to be 0.26 to 0.53 milligram per deciliter, with normal fasting blood ammonia levels being 0.1 to 0.35 milligram per deciliter (Kirk & Bistner, 1985).
    b) LABORATORY/POSTMORTEM -
    1) Animals bloat rapidly and carcasses seem to decompose more rapidly than normal. The odor of ammonia is often present in rumen contents and tissues. There are no definitive lesions but pulmonary edema, petecchial hemorrhages and generalized congestion are common findings (Beasley et al, 1989).

Kinetics

    11.5.1) ABSORPTION
    A) RUMINANT
    1) The amount of ammonia that can be utilized by the rumen microbes depends on the number of microbes and how rapidly they are growing. Ammonia produced beyond the capacity of microbial utilization results in ammonia overflow (absorption from the rumen and/or intestines) (Howard, 1986).
    2) The rumen microbes use ammonia for protein synthesis which is furnished most economically from NPN (urea or ammonia) (Howard, 1986).
    3) Signs of toxicosis which follow the ingestion of NPN sources or ammonium salts occur as a result of the absorption of ammonia following its release in the digestive tract.
    4) The rate of release of ammonia from urea depends primarily upon the amount of NPN ingested, the amount of urease present in the rumen, and the pH of the rumen contents. If the rumen pH is less than 6.2, the major fraction of the nitrogen released from urea exists as the charged ammonium ion (NH4+) which is highly water soluble and poorly absorbed. At pH 9.0, NH3/NH4+ equals one and large amounts of ammonia are available for absorption.
    5) If the level of ammonia in the blood becomes greater than the liver's capacity to detoxify it, the result is hyperammonemia (Haliburton et al, 1989).
    B) SMALL ANIMALS
    1) Ammonium is normally absorbed from the lower intestinal tract, removed via the portal circulation, transported to the liver, and converted to urea by the urea cycle (Kirk & Bistner, 1985).
    11.5.2) DISTRIBUTION
    A) RUMINANT
    1) If rumen flora are unable to utilize excess ammonia produced during urealysis, the ammonia dissolves in rumen fluids, takes on protons to form ammonium ions which increases the pH. As the pH rises, the ammonium ions are no longer formed and the concentration of (uncharged) ammonia (NH3) in rumen fluids and blood increases rapidly and clinical signs of ammonia toxicosis become apparent.
    11.5.3) METABOLISM
    A) GENERAL
    1) Absorbed ammonia is normally incorporated into the urea cycle and excreted as urea in the urine. The conversion of ammonia to urea (which is more water soluble and excretable) occurs in the liver, and elevation of blood ammonia represents a failure of the liver to convert the excess portal blood ammonia to urea. Ammonia inhibits the tricarboxylic acid cycle and there is a compensatory increase in anaerobic glycolysis with resultant lactic-acidemia. High brain ammonia concentration interferes with cerebral energy metabolism and the sodium-potassium-ATPase pump (Beasley et al, 1989).
    2) The primary mechanism of ammonia toxicosis appears to be inhibition of the citric acid cycle. It is postulated that ammonia saturates the glutamine-synthesizing system, which results in decreased energy production and ultimately inhibits cellular respiration (Haliburton et al, 1989).
    a) CATTLE
    1) Research on four calves (161 kg average body weight) that were given ammonium chloride via the femoral vein indicated that hyperammonemia reduced hepatic glucose output and glucose-mediated pancreatic insulin release (Fernandey, 1990).
    2) Research in seven steers given ammonium chloride via right jugular vein supported the hypothesis that the hyperglycemia observed during hyperammonemia may result from under-utilization of glucose by insulin-sensitive tissues (Fernandez, 1988).
    b) HORSE
    1) Inhibition of alphaketoglutarate decarboxylation may be the primary site of ammonia intoxication (Humphreys, 1988).
    c) CAT
    1) The proposed mechanisms of ammonia intoxication include a direct depressant effect on neuronal membranes associated with altered ion transport, interference with mitochondrial metabolism, diminution of excitatory neurotransmitters, decrease in cerebral energy stores and alteration of the blood brain barrier (Kirk, 1986).
    2) Another route of ammonia detoxification is in the kidney, through glutamine synthesis (Kirk, 1986).
    11.5.4) ELIMINATION
    A) SPECIFIC TOXIN
    1) Urea provides a non-toxic means for excretion of ammonia. It is excreted by the kidneys primarily by glomerular filtration (Smith, 1990).

Pharmacology Toxicology

    A) GENERAL
    1) There can be a fourfold or more rise in blood ammonia in some toxic liver diseases because the urease needed to convert ammonia to urea is found only in the liver (Smith, 1990).
    2) In the cat, ammonia decreases postsynaptic inhibition of cortical, spinal and trochlear motor neurons (Haliburton et al, 1989).

Sources

    A) SPECIFIC TOXIN
    1) NON PROTEIN NITROGEN -
    a) Urea is the major non-protein nitrogen UPN source in use today and is commonly incorporated into range blocks, range cubes, and molasses - NPN combinations. Other NPN sources include feed grade biuret, gelatinized starch urea product, diammonium phosphate, ammonium phosphate solution, ammoniated rice hulls, ammoniated cottonseed meal, ammonium sulfate and mono-ammonium phosphate (Beasley et al, 1989).
    b) Non protein nitrogen (NPN) is any source of nitrogen that is not present in a polypeptide (precipitable protein) form. NPN is converted by ruminal microorganisms to ammonia, which is then combined with the carbohydrate-derived keto acids to form amino acids, the basic building blocks for protein synthesis (Haliburton et al, 1989).
    c) Dry and liquid fertilizers containing ammonia, ammonium salts, or urea may be accidentally ingested (Beasley et al, 1989).
    2) AMMONIUM SALTS -
    a) Ammonium salts have caused intoxication in animals; ammonium-nitrate, acetate, lactate, and chloride have been studied in cattle (Humphreys, 1988).
    b) AMMONIATION - Ammonia treatment of silage inhibits initial plant respiration and proteolysis, thereby conserving silage energy and natural protein. The silage is also protected from mold and yeast growth while perserving its ensiled energy (Howard, 1986).
    3) SILAGE -
    a) Addition of ammonia to grain silages is commonly used for silage treatment. From this process the animal receives most of the ammonia as the free ammonium salts of silage organic acid.
    4) GASEOUS AMMONIA -
    a) Ammonia is lighter than air, has a pungent odor, and concentrations increase due to agitation of manure (Beasley et al, 1989).
    b) Gaseous ammonia has caused toxicity (Humphreys, 1988).
    c) Ammonia (NH3) is the toxic air pollutant most frequently found in high concentrations in animal facilities. Excessive tearing and clear or purulent nasal discharge are common symptoms of NH3 - vapor toxicosis. Even at levels less than 100 ppm the primary effect is as a chronic stressor, since it irritates the respiratory mucosa from the nose to the lungs (Kirk, 1986).
    d) ANHYDROUS NH3 ("gas-NH3") - This form is used as an agricultural nitrogen fertilizer. The eye is very vulnerable to gas-NH3 and permanent or impaired loss of eyesight, respiratory problems, and skin burns are the result of exposure.
    5) INTESTINAL UREA -
    a) The toxin most frequently incriminated in hepatic encephalopathy is ammonia, which is generated by urease-producing colonic bacteria. An acute hepatic failure, impaired hepatic extraction or metabolism of ammonia results in excessive accumulation of ammonia in the blood, brain and CSF fluid. Many factors increase ammonia production in the gut, including high-protein diets, gastrointestinal hemorrhage, and constipation (Kirk, 1986).
    b) Ammonia is a major waste product of protein catabolism. It is produced primarily by microbial degradation of endogenous urea and dietary amines within the intestinal tract (Kirk, 1986).
    6) AMMONIUM CHLORIDE -
    a) Ammonium chloride is used as a urinary acidifier and reduces the incidence of urinary calculi in steers and lambs when included at 0.5% of the ration (Smith, 1990).

Other

    A) OTHER
    1) GENERAL
    a) DIAGNOSIS -
    1) Clinical signs and history of acute illness after ingestion of urea or other NPN sources
    2) Chemical analysis of suspect feed, rumen fluid, jugular whole blood or serum are necessary for a definitive diagnosis.
    3) Blood ammonia values ranging from 1 to 4 mg/100 ml and rumen values greater than 80 mg/100 ml are compatible with a diagnosis of ammonia toxicosis.
    4) Samples of blood and urine should be collected immediately after death and frozen if tests cannot be done in 1 hour.
    5) Significant increases in hematocrit, blood ammonia, blood glucose, BUN, serum potassium and phosphorus, rumen pH, rumen ammonia, and SGPT are commonly seen. Blood pH and urine production are decreased (Beasley et al, 1989).
    b) SPECIMENS -
    1) For ammonia analysis the following specimens are required: whole blood or serum - 5 mL; rumen contents (composite) - 100 gm; or urine - 5 mL. These samples should be frozen or have 1 to 2 drops of saturated HgCl2 added (Howard, 1986).
    2) Analysis of free ammonia in whole blood, rumen fluid, vitreous fluid and cerebrospinal fluid can be used for confirmation of ammonia toxicosis when the specimens are collected and stored properly (Haliburton et al, 1989).
    3) Normal blood and vitreous ammonia concentrations in cattle are less than 0.5 mg/dL. Clinical signs are seen at blood ammonia concentrations of 1 mg/dL while death is associated with blood and vitreous ammonia concentrations of 2 mg/dL or greater (Haliburton et al, 1989).
    c) DIFFERENTIAL DIAGNOSIS -
    1) Toxicosis from organochlorine or organophosphorus insecticides, cyanide, protein or grain engorgement, enterotoxemia, meningitis and encephalitis
    2) Rumen pH values should help differentiate these disorders.
    d) AMMONIATED FEED SYNDROME/BOVINE BONKERS -
    1) Is a CNS syndrome reported in cattle after ingestion of higher quality ammoniated forages, ammoniated molasses and molasses-urea-protein blocks.
    2) CLINICAL SIGNS - Cows and/or calves nursing affected cows exhibit a sudden onset of hyperexcitability, wild running, circling, seizures, and often death. The only lesions found are from trauma.
    3) TREATMENT - None
    4) DIAGNOSIS - History of ingestion of ammoniated feed, clinical signs, no lesions, identification of 4-MI in feedstuffs.

General Bibliography

    1) 40 CFR 372.28: Environmental Protection Agency - Toxic Chemical Release Reporting, Community Right-To-Know, Lower thresholds for chemicals of special concern. National Archives and Records Administration (NARA) and the Government Printing Office (GPO). Washington, DC. Final rules current as of Apr 3, 2006.
    2) 40 CFR 372.65: Environmental Protection Agency - Toxic Chemical Release Reporting, Community Right-To-Know, Chemicals and Chemical Categories to which this part applies. National Archives and Records Association (NARA) and the Government Printing Office (GPO), Washington, DC. Final rules current as of Apr 3, 2006.
    3) 49 CFR 172.101 - App. B: Department of Transportation - Table of Hazardous Materials, Appendix B: List of Marine Pollutants. National Archives and Records Administration (NARA) and the Government Printing Office (GPO), Washington, DC. Final rules current as of Aug 29, 2005.
    4) 49 CFR 172.101: Department of Transportation - Table of Hazardous Materials. National Archives and Records Administration (NARA) and the Government Printing Office (GPO), Washington, DC. Final rules current as of Aug 11, 2005.
    5) 62 FR 58840: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 1997.
    6) 65 FR 14186: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 2000.
    7) 65 FR 39264: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 2000.
    8) 65 FR 77866: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 2000.
    9) 66 FR 21940: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 2001.
    10) 67 FR 7164: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 2002.
    11) 68 FR 42710: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 2003.
    12) 69 FR 54144: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 2004.
    13) AAR: Emergency Handling of Hazardous Material in Surface Transportation, Hazardous Materials Systems (BOE), Association of American Railroads, Washington, DC, 1987.
    14) AAR: Emergency Handling of Hazardous Materials in Surface Transportation, Bureau of Explosives, Association of American Railroads, Washington, DC, 1994.
    15) AAR: Emergency Handling of Hazardous Materials in Surface Transportation, Bureau of Explosives, Association of American Railroads, Washington, DC, 2000.
    16) ACGIH: Documentation of the Threshold Limit Values and Biological Exposure Indices, 6th ed, Am Conference of Govt Ind Hyg, Inc, Cincinnati, OH, 1991, pp 58-59.
    17) AIHA: 2006 Emergency Response Planning Guidelines and Workplace Environmental Exposure Level Guides Handbook, American Industrial Hygiene Association, Fairfax, VA, 2006.
    18) ASTI : ASTI News Journal. Multi Channel Media International . Dallas, TX, USA. 1999. Available from URL: http:/asti.org/news/index.cgi.
    19) ATSDR: ATSDR Science Corner: Ammonia Patient Information. Agency for Toxic Substances and Disease Registry, US Dept of Health and Human Services. Atlanta, GA, USA. 1999. Available from URL: URL: http://www.atsdr.cdc.gov/mmg2.html.
    20) ATSDR: Toxicological Profile for Ammonia. Agency for Toxic Substances and Disease Registry. Atlanta, GA. 2004. Available from URL: http://www.atsdr.cdc.gov/toxprofiles/tp126.pdf. As accessed 8 Sept, 2005.
    21) Aceto T Jr, Terplan K, & Fiore RR: Chemical burns of the esophagus in children and glucocorticoid therapy. J Med 1970; 1:101-109.
    22) Adam JS & Brick HG: Pediatric caustic ingestion. Ann Otol Laryngol 1982; 91:656-658.
    23) Allen RE, Thoshinsky MJ, & Stallone RJ: Corrosive injuries of the stomach. Arch Surg 1970; 100:409-413.
    24) Allison SM & Prosser JI: Ammonia oxidation at low pH by attached populations of nitrifying bacteria. Soil Biol Biochem 1993; 25:935-941.
    25) American Conference of Governmental Industrial Hygienists : ACGIH 2010 Threshold Limit Values (TLVs(R)) for Chemical Substances and Physical Agents and Biological Exposure Indices (BEIs(R)), American Conference of Governmental Industrial Hygienists, Cincinnati, OH, 2010.
    26) Andanson J, Berenger J, & Castela R: Detection of chronic ammonia poisoning in joint plant medical services. Rev Med Travail 1976; 4:293-300.
    27) Anderson KD, Touse TM, & Randolph JG: A controlled trial of corticosteroids in children with corrosive injury of the esophagus. N Engl J Med 1990; 323:637-640.
    28) Ansell-Edmont: SpecWare Chemical Application and Recommendation Guide. Ansell-Edmont. Coshocton, OH. 2001. Available from URL: http://www.ansellpro.com/specware. As accessed 10/31/2001.
    29) Artigas A, Bernard GR, Carlet J, et al: The American-European consensus conference on ARDS, part 2: ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling.. Am J Respir Crit Care Med 1998; 157:1332-1347.
    30) Arwood R, Hammond J, & Ward GG: Ammonia inhalation. J Trauma 1985; 25:444-447.
    31) Atkins DHF & Lee DS: Indoor concentrations of ammonia and the potential contribution of humans to atmospheric budgets. Atmos Environ Pt A-Gen Top 1993; 27:1-7.
    32) Auerbach C & Robson JM: Proc R Soc Edinburgh Sect B 1947; 62B:284-291.
    33) Augspurger T, Keller AE, Black MC, et al: Water quality guidance for protection of freshwater mussels (Unionidae) from ammonia exposure. Environ Toxicol Chem 2003; 22/11:2569-2575.
    34) Bartsch MR, Newton TJ, Allran JW, et al: Effects of pore-water ammonia on in situ survival and growth of juvenile mussels (Lampsilis cardium) in the St. Croix riverway, Wisconsin, USA. Environ Toxicol Chem 2003; 22/11:2561-2568.
    35) Bata Shoe Company: Industrial Footwear Catalog, Bata Shoe Company, Belcamp, MD, 1995.
    36) Beare JDL, Wilson RS, & Marsh RJ: Ammonia burns of the eye: an old weapon in new hands. Br Med J 1988; 296:590.
    37) Beasley VR, Dorman DC, & Fikes JD: A systems affected approach to veterinary toxicology, University of Illinois, Urbana, IL, 1989.
    38) Best Manufacturing: ChemRest Chemical Resistance Guide. Best Manufacturing. Menlo, GA. 2002. Available from URL: http://www.chemrest.com. As accessed 10/8/2002.
    39) Best Manufacturing: Degradation and Permeation Data. Best Manufacturing. Menlo, GA. 2004. Available from URL: http://www.chemrest.com/DomesticPrep2/. As accessed 04/09/2004.
    40) Birken GA, Fabri PJ, & Carey LC: Acute ammonia intoxication complicating multiple trauma. J Trauma 1981; 21:820-822.
    41) Blagodatin VM: Gig Tr I Prof Zabol 1968; 12:35-37.
    42) Boardman GD, Starbuck SM, Hudgins DB, et al: Toxicity of ammonia to three marine fish and three marine invertebrates. Environ Toxicol 2004; 19(2):134-142.
    43) Boss Manufacturing Company: Work Gloves, Boss Manufacturing Company, Kewanee, IL, 1998.
    44) Boukthir S, Fetni I, Mrad SM, et al: [High doses of steroids in the management of caustic esophageal burns in children]. Arch Pediatr 2004; 11(1):13-17.
    45) Boyd EM, MacLachlan ML, & Perry WF: Experimental ammonia gas poisoning in rabbits and cats. J Ind Hyg Toxicol 1944; 26:29-34.
    46) Braunwald E, Isselbacher KJ, & Petersdorf RG: Principles of Internal Medicine, 11th ed, McGraw-Hill, New York, NY, 1987.
    47) Brautbar N, Wu MP, & Richter ED: Chronic ammonia inhalation and interstitial pulmonary fibrosis: a case report and review of the literature. Archives Environ Health 2003; 58(9):592-596.
    48) Briski F, Cerjanstefanovic S, & Sipos L: Monitoring of nitrifying processes in ground water by ion chromatography. Internat J Environ Anal Chem 1993; 52:137-148.
    49) Brower RG, Matthay AM, & Morris A: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Eng J Med 2000; 342:1301-1308.
    50) Budavari S: The Merck Index, 11th ed, Merck & Co, Inc, Rahway, NJ, 1989.
    51) Budavari S: The Merck Index, 12th ed, Merck & Co, Inc, Whitehouse Station, NJ, 1996, pp 87.
    52) Burgess JL, Kirk M, Borron SW, et al: Emergency department hazardous materials protocol for contaminated patients. Ann Emerg Med 1999; 34(2):205-212.
    53) Burns TR, Macd ML, & Greenberg SD: Ultrastructure of acute ammonia toxicity in the human lung. Am J Forens Med Pathol 1985; 6:204-210.
    54) CHRIS : CHRIS Hazardous Chemical Data. US Department of Transportation, US Coast Guard. Washington, DC (Internet Version). Edition expires January/31/2001; provided by Truven Health Analytics Inc., Greenwood Village, CO.
    55) CHRIS: CHRIS Hazardous Chemical Data. US Department of Transportation, US Coast Guard. Washington, DC (Internet Version). Edition expires 2005; provided by Truven Health Analytics Inc., Greenwood Village, CO.
    56) Caplin M: Ammonia gas poisoning - forty-seven cases in a London shelter. Lancet 1941; 2:95-96.
    57) Caravati EM: Alkali. In: Dart RC, ed. Medical Toxicology, Lippincott Williams & Wilkins, Philadelphia, PA, 2004.
    58) Cardona JC & Daly JF: Management of corrosive esophagitis. Analysis of treatment methods and results. State J Med 1964; 64:2307-2313.
    59) Caros T: Rev Roum Morphol Embryol Physiol Morphol Embryol 1978; 24:107-110.
    60) Cataletto M: Respiratory Distress Syndrome, Acute(ARDS). In: Domino FJ, ed. The 5-Minute Clinical Consult 2012, 20th ed. Lippincott Williams & Wilkins, Philadelphia, PA, 2012.
    61) Cattan P, Munoz-Bongrand N, & Berney T: Extensive abdominal surgery after caustic ingestion. Ann Surg 2000; 231:519-523.
    62) Chassin JL & Slattery LR: Jejunal stricture due to ingestion of ammonia. JAMA 1953; 152:134-136.
    63) ChemFab Corporation: Chemical Permeation Guide Challenge Protective Clothing Fabrics, ChemFab Corporation, Merrimack, NH, 1993.
    64) Chen JC & Kou YZ: Effects of ammonia on growth and molting of Penaeus japonicus juveniles. Aquaculture 1992; 104:249-260.
    65) Chen YM, Ott DJ, & Thompson JN: Progressive roentgenographic appearance of caustic esophagitis. South Med J 1988; 81:724-728.
    66) Cheng SY, Lee WC, Shieh LW, et al: Increased production and excretion of urea in the kuruma shrimp (Marsupenaeus japonicus) exposed to combined environments of increased ammonia and nitrite. Arch Environ Contam Toxicol 2004; 47(3):352-362.
    67) Chiene KY, Wang PY, & Lu KS: Esophagoplasty of corrosive stricture of the esophagus. Ann Surg 1974; 179:510-515.
    68) Chmielewskahorvathova E, Konecny J, & Bosan Z: Ammonia removal from tannery wastewaters by selective ion exchange on Slovak clinoptilolite. Z Wasser Abwasser-Acta Hydroc 1992; 5:269-272.
    69) Clayton GD & Clayton FE: Patty's Industrial Hygiene and Toxicology, Vol 2A, Toxicology, 3rd ed, John Wiley & Sons, New York, NY, 1981.
    70) Clayton GD & Clayton FE: Patty's Industrial Hygiene and Toxicology, Vol 2A, Toxicology, 4th ed, John Wiley & Sons, New York, NY, 1993, pp 756-762.
    71) Clement B & Merlin G: The contribution of ammonia and alkalinity to landfill leachate toxicity to duckweed. Sci Total Environ 1995; 170:71-79.
    72) Cleveland WW, Chandler JR, & Lawson RB: Treatment of caustic burns of the esophagus. JAMA 1963; 186:182-183.
    73) Close LG, Catlin FI, & Cohn AM: Acute and chronic effects of ammonia burns on the respiratory tract. Arch Otolaryngol 1980; 106:151-158.
    74) Colbourn P: Denitrification and N2O production in pasture soil - the influence of nitrogen supply and moisture. Agric Ecosys Environ 1992; 39:267-278.
    75) Coln D & Chang JHT: Experience with esophageal stenting for caustic burns in children. J Pediatr Surg 1986; 21:588-592.
    76) Comasec Safety, Inc.: Chemical Resistance to Permeation Chart. Comasec Safety, Inc.. Enfield, CT. 2003. Available from URL: http://www.comasec.com/webcomasec/english/catalogue/mtabgb.html. As accessed 4/28/2003.
    77) Comasec Safety, Inc.: Product Literature, Comasec Safety, Inc., Enfield, CT, 2003a.
    78) Consensus: POISINDEX(R) Editorial Board Consensus opinion poll, Irritants/Caustics Specialty Board, Micromedex, Inc, Greenwood Village, CO, 1988.
    79) Crain EF, Gershel JC, & Mezey AP: Caustic ingestions. Symptoms as predictors of esophageal injury. Am J Dis Child 1984a; 138(9):863-865.
    80) Crain EF, Gershel JC, & Mezey AP: Caustic ingestions; symptoms as predictors of esophageal injury. Am J Dis Child 1984; 138:863-865.
    81) Crawford CG & Wangsness DJ: Effects of advanced wastewater treatment on the quality of White River, Indiana. Water Res Bull 1991; 27:769-779.
    82) DFG: List of MAK and BAT Values 2002, Report No. 38, Deutsche Forschungsgemeinschaft, Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area, Wiley-VCH, Weinheim, Federal Republic of Germany, 2002.
    83) Dalton ML & Bricker DL: Anhydrous ammonia burn of the respiratory tract. Texas Med 1978; 74:51-54.
    84) Davis WM, Madden JW, & Peacock EE Jr: A new approach to the control of esophageal stenosis. Ann Surg 1972; 176:469-476.
    85) Demerec M: Am Nat 1951; 85:119-136.
    86) Desanto JT, Nagomi W, & Liechty EA: Blood ammonia concentration in cord blood during pregnancy. Early Human Dev 1993; 33:1-8.
    87) Dogan Y, Erkan T, Cokugras FC, et al: Caustic gastroesophageal lesions in childhood: an analysis of 473 cases. Clin Pediatr (Phila) 2006; 45(5):435-438.
    88) Donham KJ: Association of environmental air contaminants with disease and productivity in swine. Am J Vet Res 1991; 52:1723-1730.
    89) DuPont: DuPont Suit Smart: Interactive Tool for the Selection of Protective Apparel. DuPont. Wilmington, DE. 2002. Available from URL: http://personalprotection.dupont.com/protectiveapparel/suitsmart/smartsuit2/na_english.asp. As accessed 10/31/2002.
    90) DuPont: Permeation Guide for DuPont Tychem Protective Fabrics. DuPont. Wilmington, DE. 2003. Available from URL: http://personalprotection.dupont.com/en/pdf/tyvektychem/pgcomplete20030128.pdf. As accessed 4/26/2004.
    91) DuPont: Permeation Test Results. DuPont. Wilmington, DE. 2002a. Available from URL: http://www.tyvekprotectiveapprl.com/databases/default.htm. As accessed 7/31/2002.
    92) Dupuy R, Oblonsky D, & Chauveinc L: Toxic gastritis due to ammonia. Arch Franc Mal l'Appareil Dig 1968; 57:819-820.
    93) Dworkin MS, Patel A, & Fennell M: An outbreak of ammonia poisoning from chicken tenders served in a school lunch. J Food Prot 2004; 67:1299-1302.
    94) EPA: 40 CFR Part 172, Index, Identification Number Cross Reference Index to Proper Shipping Names in Section 172.101, Environmental Protection Agency, Washington, DC, 1994.
    95) EPA: EPA chemical profile on ammonia, Environmental Protection Agency, Washington, DC, 1985.
    96) EPA: Search results for Toxic Substances Control Act (TSCA) Inventory Chemicals. US Environmental Protection Agency, Substance Registry System, U.S. EPA's Office of Pollution Prevention and Toxics. Washington, DC. 2005. Available from URL: http://www.epa.gov/srs/.
    97) ERG: Emergency Response Guidebook. A Guidebook for First Responders During the Initial Phase of a Dangerous Goods/Hazardous Materials Incident, U.S. Department of Transportation, Research and Special Programs Administration, Washington, DC, 2004.
    98) Emmett BA & Quarmby C: The effect of harvesting intensity on the fate of applied N-15-ammonium to the organic horizons of a coniferous forest in N Wales. Biogeochem 1991; 15:47-63.
    99) Erisman JW & Wyers GP: Continuous measurements of surface exchange of SO(2) and NH(3) - implications for their possible interaction in the deposition process. Atmos Environ Pt A-Gen Top 1993; 27:1937-1949.
    100) Estrera A, Taylor W, & Mills LJ: Corrosive burns of the esophagus and stomach: a recommendation of an aggressive surgical approach. Ann Thorac Surg 1986; 41:276-283.
    101) Faigel HC: Mixtures of household cleaning agents. N Engl J Med 1964; 271:618.
    102) Fang HY, Chou MS, & Huang CW: Nitrification of ammonia-nitrogen in refinery wastewater. Water Res 1993; 27:1761-1765.
    103) Ferguson MK, Migliore M, & Staszak VM: Early evaluation and therapy for caustic esophageal injury. Am J Surg 1989; 157:116-120.
    104) Ferguson WS: J Occop Med 1977; 19:319-326.
    105) Fernandez JM, Croom WJ, & Johnson AD: Subclinical ammonia toxicity in steers: effects on blood metabolite and regulatory hormone concentrations. J Anim Sci 1988; 66:3259-3266.
    106) Finkel AJ: Hamilton and Hardy's Industrial Toxicology, 4th ed, John Wright, PSG Inc, Boston, MA, 1983.
    107) Fisher TR, Peele ER, & Ammerman JW: Nutrient limitation of phytoplankton in Chesapeake Bay. Marine Ecol - Progr Ser 1992; 82:51-63.
    108) Flury KE, Dines DE, & Rodarte JR: Airway obstruction due to inhalation of ammonia. Mayo Clin Proc 1983; 58:389-393.
    109) Gandhi RP, Cooper A, & Barlow BA: Successful management of esophageal stricture without resection or replacement. J Pediatr 1989; 24:745-750.
    110) Gapany-Gapanavicius M, Molho M, & Tirosh M: Chloramine-induced pneumonitis from mixing household cleaning agents. Br Med J 1982; 285:1086.
    111) Gaudreault P, Parent M, & McGuigan MA: Predictability of esophageal injury from signs and symptoms: a study of caustic ingestion in 378 children. Pediatrics 1983; 71:761-770.
    112) Gaudreault P, Parent M, McGuigan MA, et al: Predictability of esophageal injury from signs and symptoms: a study of caustic ingestion in 378 children. Pediatrics 1983a; 71(5):767-770.
    113) Gorman RL, Khin-Maung-Gyi MT, & Klein-Schwartz W: Initial symptoms as predictors of esophageal injury in alkaline corrosive ingestions. Am J Emerg Med 1992; 10:89-94.
    114) Gossot D, Tagny G, & Sarfati E: Les lesions digestives provoquees par l'ingestion d'ammoniaque. Gastroenterol Clin Biol 1990; 14:191-192.
    115) Grant WM: Toxicology of the Eye, 4th ed, Charles C Thomas, Springfield, IL, 1993.
    116) Grieve AW, Davis P, Dhillon S, et al: A clinical review of the management of frostbite. J R Army Med Corps 2011; 157(1):73-78.
    117) Guardian Manufacturing Group: Guardian Gloves Test Results. Guardian Manufacturing Group. Willard, OH. 2001. Available from URL: http://www.guardian-mfg.com/guardianmfg.html. As accessed 12/11/2001.
    118) Guillen JL, Endo M, & Turnbull JF: Depressed growth rate and damage to the cartilage of Red Sea bream larvae associated with exposure to ammonia. Nippon Suisan Gakkaishi 1993; 59:1231-1234.
    119) Gundogdu HZ, Tanyel FC, & Buyukpamukcu N: Conservative treatment of caustic esophageal strictures in children. J Pediatr Surg 1992; 27:767-770.
    120) Gupta SK, Croffie JM, & Fitzgerald JF: Is esophagogastroduodenoscopy necessary in all caustic ingestions?. J Ped Gastroenterol Nutr 2001; 32:50-53.
    121) HSDB : Hazardous Substances Data Bank. National Library of Medicine. Bethesda, MD (Internet Version). Edition expires 1992; provided by Truven Health Analytics Inc., Greenwood Village, CO.
    122) HSDB : Hazardous Substances Data Bank. National Library of Medicine. Bethesda, MD (Internet Version). Edition expires 2005; provided by Truven Health Analytics Inc., Greenwood Village, CO.
    123) HSDB : Hazardous Substances Data Bank. National Library of Medicine. Bethesda, MD (Internet Version). Edition expires January/31/2001; provided by Truven Health Analytics Inc., Greenwood Village, CO.
    124) Haas CF: Mechanical ventilation with lung protective strategies: what works?. Crit Care Clin 2011; 27(3):469-486.
    125) Hallam MJ, Cubison T, Dheansa B, et al: Managing frostbite. BMJ 2010; 341:c5864-.
    126) Haller JA & Bachman K: The comparative effect of current therapy on experimental caustic burns of the esophagus. Pediatrics 1964; 236-245.
    127) Haller JA, Andrews HG, & White JJ: Pathophysiology and management of acute corrosive burns of the esophagus. J Pediatr Surg 1971; 6:578-584.
    128) Hathaway GH, Proctor NH, & Hughes JP: Chemical Hazards of the Workplace, 3rd ed, Van Nostrand Reinhold Company, New York, NY, 1991.
    129) Hathaway GJ, Proctor NH, & Hughes JP: Chemical Hazards of the Workplace, 4th ed, Van Nostrand Reinhold Company, New York, NY, 1996.
    130) Hatton DV, Leach CS, & Beaudet AL: Collagen breakdown and ammonia inhalation. Arch Environ Health 1979; 34:83-87.
    131) Hawkins DB, Demeter MJ, & Barnett TE: Caustic ingestion: controversies in management. A review of 214 cases. Laryngoscope 1980; 90:98-109.
    132) Helmers S, Top FH, & Knapp LW: Ammonia and eye injuries in agriculture. Sight Saving Review 1971a; 41:9-11.
    133) Helmers S, Top FH, & Knapp LW: Ammonia injuries in agriculture. J Iowa Med Soc 1971; 61:271-280.
    134) Herskowitz IH: Genetics 1955; 40:76-89.
    135) Highman VN: Early rise in intraocular pressure after ammonia burns. Br Med J 1969; 2:359-360.
    136) Hogan RB & Polter DE: Nonsurgical management of lye-induced antral strictures with hydrostatic balloon dilation. Gastrointest Endosc 1986; 32:228-230.
    137) Homan CS, Maitra SR, & Lane BP: Effective treatment of acute alkali injury of the esopahgus with early saline dilution therapy. Ann Emerg Med 1993; 22:178-182.
    138) Homan CS, Maitra SR, & Lane BP: Histopathologic evaluation of the therapeutic efficacy of water and mild dilution for esophageal acid injury. Acad Emerg Med 1995; 2:587-591.
    139) Homan CS, Maitra SR, & Lane BP: Therapeutic effects of water and milk for acute alkali injury of the esophagus. Ann Emerg Med 1994; 24:14-19.
    140) Honcharak L & Marcus S: Dilution in corrosive ingestions: primum non nocere? (Abstract). Vet Human Toxicol 1989; 31:338.
    141) Howard JL: Current Veterinary Therapy: Food Animal Practice, 2, Saunders, Philadelphia, PA, 1986.
    142) Howell JM, Dalsey WC, & Hartsell FW: Steroids for the treatment of corrosive esophageal injury: a statistical analysis of past studies. Am J Emerg Med 1992; 10:421-425.
    143) Howell JM: Alkaline ingestions. Ann Emerg Med 1987; 15:820-825.
    144) Hughes WF: Alkali burns of the eye. I. Review of the literature and summary of present knowledge. Arch Ophthalmol 1946a; 35:423-449.
    145) Humphreys DJ: Veterinary Toxicology, 3rd ed, Bailliere Tindall, London, UK, 1988.
    146) Huy PTB & Celerier M: Management of severe caustic stenosis of the hypopharynx and esophagus by ileocolic transposition via suprahyoid or transepiglottic approach. Ann Surg 1988; 207:439-445.
    147) IARC Working Group on the Evaluation of Carcinogenic Risks to Humans : IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: 1,3-Butadiene, Ethylene Oxide and Vinyl Halides (Vinyl Fluoride, Vinyl Chloride and Vinyl Bromide), 97, International Agency for Research on Cancer, Lyon, France, 2008.
    148) IARC Working Group on the Evaluation of Carcinogenic Risks to Humans : IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Formaldehyde, 2-Butoxyethanol and 1-tert-Butoxypropan-2-ol, 88, International Agency for Research on Cancer, Lyon, France, 2006.
    149) IARC Working Group on the Evaluation of Carcinogenic Risks to Humans : IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Household Use of Solid Fuels and High-temperature Frying, 95, International Agency for Research on Cancer, Lyon, France, 2010a.
    150) IARC Working Group on the Evaluation of Carcinogenic Risks to Humans : IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Smokeless Tobacco and Some Tobacco-specific N-Nitrosamines, 89, International Agency for Research on Cancer, Lyon, France, 2007.
    151) IARC Working Group on the Evaluation of Carcinogenic Risks to Humans : IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Some Non-heterocyclic Polycyclic Aromatic Hydrocarbons and Some Related Exposures, 92, International Agency for Research on Cancer, Lyon, France, 2010.
    152) IARC: List of all agents, mixtures and exposures evaluated to date - IARC Monographs: Overall Evaluations of Carcinogenicity to Humans, Volumes 1-88, 1972-PRESENT. World Health Organization, International Agency for Research on Cancer. Lyon, FranceAvailable from URL: http://monographs.iarc.fr/monoeval/crthall.html. As accessed Oct 07, 2004.
    153) ICAO: Technical Instructions for the Safe Transport of Dangerous Goods by Air, 2003-2004. International Civil Aviation Organization, Montreal, Quebec, Canada, 2002.
    154) ILC Dover, Inc.: Chemical Compatibility Chart. ILC Dover, Inc.. Frederica, DE. 1998a. Available from URL: http://www.ilcdover.com/WebDocs/chart.pdf; http://www.ilcdover.com/Products/ProtSuits/Ready1/chart.htm. As accessed 12/15/2001.
    155) ILC Dover, Inc.: Ready 1 The Chemturion Limited Use Chemical Protective Suit, ILC Dover, Inc., Frederica, DE, 1998.
    156) ITI: Toxic and Hazardous Industrial Chemicals Safety Manual, The International Technical Information Institute, Tokyo, Japan, 1988.
    157) ITI: Toxic and Hazardous Industrial Chemicals Safety Manual, The International Technical Information Institute, Tokyo, Japan, 1995.
    158) Industrial Scientific: Industrial Scientific Corporation. Industrial Scientific Corporation. Oakdale, PA, USA. 1999. Available from URL: http://www.indsci.com/.
    159) International Agency for Research on Cancer (IARC): IARC monographs on the evaluation of carcinogenic risks to humans: list of classifications, volumes 1-116. International Agency for Research on Cancer (IARC). Lyon, France. 2016. Available from URL: http://monographs.iarc.fr/ENG/Classification/latest_classif.php. As accessed 2016-08-24.
    160) International Agency for Research on Cancer: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. World Health Organization. Geneva, Switzerland. 2015. Available from URL: http://monographs.iarc.fr/ENG/Classification/. As accessed 2015-08-06.
    161) Iwaoka WT: Cancer Lett (Ireland) 1981; 12:335-341.
    162) Jacquin F, Cheloufi H, & Vong PC: Immobilization and mineralization kinetics of a nitrogen fertilizer in calcareous clayey soil (Rendzina). Sci Total Environ 1992; 118:271-278.
    163) Janda V & Rudovsky J: Removal of ammonia from drinking water by biological nitrification. Aqua 1994; 43:120-125.
    164) Kamijo Y, Kondo I, Kokuto M, et al: Miniprobe ultrasonography for determining prognosis in corrosive esophagitis. Am J Gastroenterol 2004; 99(5):851-854.
    165) Kappler, Inc.: Suit Smart. Kappler, Inc.. Guntersville, AL. 2001. Available from URL: http://www.kappler.com/suitsmart/smartsuit2/na_english.asp?select=1. As accessed 7/10/2001.
    166) Kimberly-Clark, Inc.: Chemical Test Results. Kimberly-Clark, Inc.. Atlanta, GA. 2002. Available from URL: http://www.kc-safety.com/tech_cres.html. As accessed 10/4/2002.
    167) Kirk GJD & Rachhpalsingh: Simultaneous transfer across an air water interface of gases that interact through acid base reactions. Atmos Environ 1992; 26:1651-1660.
    168) Kirk RW & Bistner SI: Handbook of Veterinary Procedures and Emergency Treatment, 4th ed, Saunders, Philadelphia, PA, 1985.
    169) Kirk RW: Current Veterinary Therapy IX, Saunders, Philadelphia, PA, 1986.
    170) Kirk RW: Current Veterinary Therapy X, Saunders, Philadelphia, PA, 1989.
    171) Kirsh MM & Ritter F: Caustic ingestion and subsequent damage to the oropharyngeal and digestive passages. Ann Thorac Surg 1976; 21:74-82.
    172) Klein J, Olson KR, & McKinney HE: Caustic injury from household ammonia. Am J Emerg Med 1985; 3:320.
    173) Knox WG, Scott JR, & Zintel HA: Bouginage and steroids used singly or in combination in experimental corrosive esophagitis. Ann Surg 1967; 166:930-941.
    174) Kocks DJ & Scott D: Ammonia-still a health hazard in the workplace. S Afr Med J 1990; 78:45.
    175) Kollef MH & Schuster DP: The acute respiratory distress syndrome. N Engl J Med 1995; 332:27-37.
    176) Kollef MH: Chronic ammonium hydroxide exposure (Letter). Ann Intern Med 1987; 107:118.
    177) Kosenko E, Kaminsky YG, & Felipo V: Chronic hyperammonemia prevents changes in brain energy and ammonia metabolites induced by acute ammonium intoxication. Biochim Biophys Acta 1993; 1180:321-326.
    178) LaCrosse-Rainfair: Safety Products, LaCrosse-Rainfair, Racine, WI, 1997.
    179) Lamireau T, Rebouissoux L, & Denis D: Accidental caustic ingestion in children: is endoscopy always mandatory?. J Ped Gastroenterol Nutr 2001; 33:81-84.
    180) Leape LL, Ashcraft AW, & Scarpelli DG: Hazard to health - liquid lye. N Engl J Med 1971; 284:578-581.
    181) Lecorre P, Lhelguen S, & Wafar M: Nitrogen source for uptake by gyrodinium cf. aureolum in a tidal front. Limnol Oceanogr 1993; 38:446-451.
    182) Leduc D, Gris P, & Leheureux P: Acute and long term respiratory damage following inhalation of ammonia. Thorax 1992; 47:755-757.
    183) Levy DM, Divertie MB, & Litzow TJ: Ammonia burns of the face and respiratory tract. JAMA 1964; 190:873-876.
    184) Lewis RJ: Hawley's Condensed Chemical Dictionary, 12th ed, Van Nostrand Reinhold Company, New York, NY, 1993, pp 62.
    185) Lewis RJ: Hawley's Condensed Chemical Dictionary, 13th ed, John Wiley & Sons, Inc, New York, NY, 1997.
    186) Lewis RJ: Sax's Dangerous Properties of Industrial Chemicals, 8th ed, Van Nostrand Reinhold Company, New York, NY, 1992a.
    187) Lewis RJ: Sax's Dangerous Properties of Industrial Materials, 10th ed, John Wiley & Sons, New York, NY, 2000a.
    188) Lewis RJ: Sax's Dangerous Properties of Industrial Materials, 8th ed, Van Nostrand Reinhold Company, New York, NY, 1992.
    189) Lewis RJ: Sax's Dangerous Properties of Industrial Materials, 9th ed, Van Nostrand Reinhold Company, New York, NY, 2000.
    190) Little AG, Naunheim KS, & Ferguson MK: Surgical management of esophageal strictures. Ann Thorac Surg 1988; 45:144-147.
    191) LoVecchio F, Hamilton R, & Sturman K: A meta-analysis of the use of steroids in the prevention of stricture formation from second degree caustic burns of the esophagus (abstract). J Toxicol-Clin Toxicol 1996; 35:579-580.
    192) Lopez GP, Dean BS, & Krenzelok EP: Oral exposure to ammonia inhalants: a report of 8 cases. Vet Human Toxicol 1988; 30:350.
    193) Lowe JE, Graham DY, & Boisaubin EV: Corrosive injury to the stomach: the natural history and role of fiberoptic endoscopy. Am J Surg 1979; 137:803.
    194) Luca D: Rev Roum MEP(Rumania) 1981; 27:245-248.
    195) Lucas CE & Ledgerwood AM: Pulmonary response of steroids in seriously injured patients. Ann Surg 1981; 194:256-261.
    196) MAPA Professional: Chemical Resistance Guide. MAPA North America. Columbia, TN. 2003. Available from URL: http://www.mapaglove.com/pro/ChemicalSearch.asp. As accessed 4/21/2003.
    197) MAPA Professional: Chemical Resistance Guide. MAPA North America. Columbia, TN. 2004. Available from URL: http://www.mapaglove.com/ProductSearch.cfm?id=1. As accessed 6/10/2004.
    198) Mar-Mac Manufacturing, Inc: Product Literature, Protective Apparel, Mar-Mac Manufacturing, Inc., McBee, SC, 1995.
    199) Marigold Industrial: US Chemical Resistance Chart, on-line version. Marigold Industrial. Norcross, GA. 2003. Available from URL: www.marigoldindustrial.com/charts/uschart/uschart.html. As accessed 4/14/2003.
    200) Marshall F II: Caustic burns of the esophagus: ten year results of aggressive care. South Med J 1979; 72:1236-1237.
    201) Martins O & Dewes T: Loss of nitrogenous compounds during composting of animal wastes. Biores Tech 1992; 42:103-111.
    202) Maull KI, Osman AP, & Maull CD: Liquid caustic ingestions: an in vitro study of the effects of buffer, neutralization, and dilution. Ann Emerg Med 1985; 4:1160-1162.
    203) Memphis Glove Company: Permeation Guide. Memphis Glove Company. Memphis, TN. 2001. Available from URL: http://www.memphisglove.com/permeation.html. As accessed 7/2/2001.
    204) Meredith JW, Kon ND, & Thompson JN: Management of injuries from liquid lye ingestion. J Trauma 1988; 28:1173-1180.
    205) Millar AJW, Numanoglu A, & Mann M: Detection of caustid oesophageal injury tiwh technetium 99m-labelled sucralfate. J Ped SUrg 2001; 36:262-265.
    206) Millea TP, Kucan JO, & Smoot EC: Anhydrous ammonia injuries. J Burn Care Rehabil 1989; 10:448-453.
    207) Mitchell MJ, Foster NW, & Shepard JP: Nutrient cycling in Huntington forest and Turkey Lakes deciduous stands - nitrogen and sulfur. Canad J Forest Res 1992; 22:457-464.
    208) Moazam F, Talbert JL, & Miller D: Caustic ingestion and its sequelae in children. South Med J 1987; 80:187-188.
    209) Montague TJ & Macneil AR: Mass ammonia inhalation. Chest 1980; 77:496-498.
    210) Montgomery Safety Products: Montgomery Safety Products Chemical Resistant Glove Guide, Montgomery Safety Products, Canton, OH, 1995.
    211) Mummert AK, Neves RJ, Newcomb TJ, et al: Sensitivity of juvenile freshwater mussels (Lampsilis fasciola, Villosa iris) to total and un-ionized ammonia. Environ Toxicol Chem 2003; 22/11:2545-2553.
    212) Murphy JV, Banwell PE, & Roberts AHN: Frostbite: pathogenesis and treatment. J Trauma 2000; 48:171-178.
    213) NFPA: Fire Protection Guide to Hazardous Materials, 11th ed, National Fire Protection Association, Quincy, MA, 1994.
    214) NFPA: Fire Protection Guide to Hazardous Materials, 12th ed, National Fire Protection Agency, Quincy, MA, 1997.
    215) NFPA: Fire Protection Guide to Hazardous Materials, 13th ed., National Fire Protection Association, Quincy, MA, 2002.
    216) NHLBI ARDS Network: Mechanical ventilation protocol summary. Massachusetts General Hospital. Boston, MA. 2008. Available from URL: http://www.ardsnet.org/system/files/6mlcardsmall_2008update_final_JULY2008.pdf. As accessed 2013-08-07.
    217) NIOSH: Pocket Guide to Chemical Hazards. National Institute for Occupational Safety and Health. Cincinnati, OH (Internet Version). Edition expires 2005; provided by Truven Health Analytics Inc., Greenwood Village, CO.
    218) NRC: Acute Exposure Guideline Levels for Selected Airborne Chemicals - Volume 1, Subcommittee on Acute Exposure Guideline Levels, Committee on Toxicology, Board on Environmental Studies and Toxicology, Commission of Life Sciences, National Research Council. National Academy Press, Washington, DC, 2001.
    219) NRC: Acute Exposure Guideline Levels for Selected Airborne Chemicals - Volume 2, Subcommittee on Acute Exposure Guideline Levels, Committee on Toxicology, Board on Environmental Studies and Toxicology, Commission of Life Sciences, National Research Council. National Academy Press, Washington, DC, 2002.
    220) NRC: Acute Exposure Guideline Levels for Selected Airborne Chemicals - Volume 3, Subcommittee on Acute Exposure Guideline Levels, Committee on Toxicology, Board on Environmental Studies and Toxicology, Commission of Life Sciences, National Research Council. National Academy Press, Washington, DC, 2003.
    221) NRC: Acute Exposure Guideline Levels for Selected Airborne Chemicals - Volume 4, Subcommittee on Acute Exposure Guideline Levels, Committee on Toxicology, Board on Environmental Studies and Toxicology, Commission of Life Sciences, National Research Council. National Academy Press, Washington, DC, 2004.
    222) Nat-Wear: Protective Clothing, Hazards Chart. Nat-Wear. Miora, NY. 2001. Available from URL: http://www.natwear.com/hazchart1.htm. As accessed 7/12/2001.
    223) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for 1,2,3-Trimethylbenzene (Proposed). United States Environmental Protection Agency. Washington, DC. 2006k. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d68a&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    224) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for 1,2,4-Trimethylbenzene (Proposed). United States Environmental Protection Agency. Washington, DC. 2006m. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d68a&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    225) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for 1,2-Butylene Oxide (Proposed). United States Environmental Protection Agency. Washington, DC. 2008d. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648083cdbb&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    226) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for 1,2-Dibromoethane (Proposed). United States Environmental Protection Agency. Washington, DC. 2007g. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064802796db&disposition=attachment&contentType=pdf. As accessed 2010-08-18.
    227) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for 1,3,5-Trimethylbenzene (Proposed). United States Environmental Protection Agency. Washington, DC. 2006l. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d68a&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    228) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for 2-Ethylhexyl Chloroformate (Proposed). United States Environmental Protection Agency. Washington, DC. 2007b. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648037904e&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    229) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Acrylonitrile (Proposed). United States Environmental Protection Agency. Washington, DC. 2007c. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648028e6a3&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    230) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Adamsite (Proposed). United States Environmental Protection Agency. Washington, DC. 2007h. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020fd29&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    231) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Agent BZ (3-quinuclidinyl benzilate) (Proposed). United States Environmental Protection Agency. Washington, DC. 2007f. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064803ad507&disposition=attachment&contentType=pdf. As accessed 2010-08-18.
    232) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Allyl Chloride (Proposed). United States Environmental Protection Agency. Washington, DC. 2008. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648039d9ee&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    233) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Aluminum Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005b. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    234) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Arsenic Trioxide (Proposed). United States Environmental Protection Agency. Washington, DC. 2007m. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480220305&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    235) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Automotive Gasoline Unleaded (Proposed). United States Environmental Protection Agency. Washington, DC. 2009a. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7cc17&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    236) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Biphenyl (Proposed). United States Environmental Protection Agency. Washington, DC. 2005j. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064801ea1b7&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    237) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Bis-Chloromethyl Ether (BCME) (Proposed). United States Environmental Protection Agency. Washington, DC. 2006n. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648022db11&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    238) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Boron Tribromide (Proposed). United States Environmental Protection Agency. Washington, DC. 2008a. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064803ae1d3&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    239) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Bromine Chloride (Proposed). United States Environmental Protection Agency. Washington, DC. 2007d. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648039732a&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    240) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Bromoacetone (Proposed). United States Environmental Protection Agency. Washington, DC. 2008e. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064809187bf&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    241) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Calcium Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005d. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    242) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Carbonyl Fluoride (Proposed). United States Environmental Protection Agency. Washington, DC. 2008b. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064803ae328&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    243) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Carbonyl Sulfide (Proposed). United States Environmental Protection Agency. Washington, DC. 2007e. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648037ff26&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    244) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Chlorobenzene (Proposed). United States Environmental Protection Agency. Washington, DC. 2008c. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064803a52bb&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    245) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Cyanogen (Proposed). United States Environmental Protection Agency. Washington, DC. 2008f. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064809187fe&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    246) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Dimethyl Phosphite (Proposed). United States Environmental Protection Agency. Washington, DC. 2009. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7cbf3&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    247) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Diphenylchloroarsine (Proposed). United States Environmental Protection Agency. Washington, DC. 2007l. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020fd29&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    248) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Ethyl Isocyanate (Proposed). United States Environmental Protection Agency. Washington, DC. 2008h. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648091884e&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    249) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Ethyl Phosphorodichloridate (Proposed). United States Environmental Protection Agency. Washington, DC. 2008i. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480920347&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    250) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Ethylbenzene (Proposed). United States Environmental Protection Agency. Washington, DC. 2008g. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064809203e7&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    251) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Ethyldichloroarsine (Proposed). United States Environmental Protection Agency. Washington, DC. 2007j. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020fd29&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    252) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Germane (Proposed). United States Environmental Protection Agency. Washington, DC. 2008j. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480963906&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    253) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Hexafluoropropylene (Proposed). United States Environmental Protection Agency. Washington, DC. 2006. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064801ea1f5&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    254) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Ketene (Proposed). United States Environmental Protection Agency. Washington, DC. 2007. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020ee7c&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    255) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Magnesium Aluminum Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005h. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    256) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Magnesium Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005g. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    257) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Malathion (Proposed). United States Environmental Protection Agency. Washington, DC. 2009k. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064809639df&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    258) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Mercury Vapor (Proposed). United States Environmental Protection Agency. Washington, DC. 2009b. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a8a087&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    259) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Methyl Isothiocyanate (Proposed). United States Environmental Protection Agency. Washington, DC. 2008k. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480963a03&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    260) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Methyl Parathion (Proposed). United States Environmental Protection Agency. Washington, DC. 2008l. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480963a57&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    261) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Methyl tertiary-butyl ether (Proposed). United States Environmental Protection Agency. Washington, DC. 2007a. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064802a4985&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    262) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Methylchlorosilane (Proposed). United States Environmental Protection Agency. Washington, DC. 2005. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5f4&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    263) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Methyldichloroarsine (Proposed). United States Environmental Protection Agency. Washington, DC. 2007i. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020fd29&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    264) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Methyldichlorosilane (Proposed). United States Environmental Protection Agency. Washington, DC. 2005a. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c646&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    265) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Nitrogen Mustard (HN1 CAS Reg. No. 538-07-8) (Proposed). United States Environmental Protection Agency. Washington, DC. 2006a. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d6cb&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    266) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Nitrogen Mustard (HN2 CAS Reg. No. 51-75-2) (Proposed). United States Environmental Protection Agency. Washington, DC. 2006b. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d6cb&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    267) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Nitrogen Mustard (HN3 CAS Reg. No. 555-77-1) (Proposed). United States Environmental Protection Agency. Washington, DC. 2006c. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d6cb&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    268) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Nitrogen Tetroxide (Proposed). United States Environmental Protection Agency. Washington, DC. 2008n. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648091855b&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    269) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Nitrogen Trifluoride (Proposed). United States Environmental Protection Agency. Washington, DC. 2009l. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480963e0c&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    270) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Parathion (Proposed). United States Environmental Protection Agency. Washington, DC. 2008o. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480963e32&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    271) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Perchloryl Fluoride (Proposed). United States Environmental Protection Agency. Washington, DC. 2009c. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7e268&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    272) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Perfluoroisobutylene (Proposed). United States Environmental Protection Agency. Washington, DC. 2009d. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7e26a&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    273) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Phenyl Isocyanate (Proposed). United States Environmental Protection Agency. Washington, DC. 2008p. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648096dd58&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    274) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Phenyl Mercaptan (Proposed). United States Environmental Protection Agency. Washington, DC. 2006d. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020cc0c&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    275) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Phenyldichloroarsine (Proposed). United States Environmental Protection Agency. Washington, DC. 2007k. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020fd29&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    276) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Phorate (Proposed). United States Environmental Protection Agency. Washington, DC. 2008q. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648096dcc8&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    277) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Phosgene (Draft-Revised). United States Environmental Protection Agency. Washington, DC. 2009e. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a8a08a&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    278) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Phosgene Oxime (Proposed). United States Environmental Protection Agency. Washington, DC. 2009f. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7e26d&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    279) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Potassium Cyanide (Proposed). United States Environmental Protection Agency. Washington, DC. 2009g. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7cbb9&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    280) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Potassium Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005c. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    281) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Propargyl Alcohol (Proposed). United States Environmental Protection Agency. Washington, DC. 2006e. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020ec91&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    282) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Selenium Hexafluoride (Proposed). United States Environmental Protection Agency. Washington, DC. 2006f. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020ec55&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    283) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Silane (Proposed). United States Environmental Protection Agency. Washington, DC. 2006g. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d523&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    284) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Sodium Cyanide (Proposed). United States Environmental Protection Agency. Washington, DC. 2009h. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7cbb9&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    285) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Sodium Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005i. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    286) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Strontium Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005f. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    287) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Sulfuryl Chloride (Proposed). United States Environmental Protection Agency. Washington, DC. 2006h. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020ec7a&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    288) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Tear Gas (Proposed). United States Environmental Protection Agency. Washington, DC. 2008s. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648096e551&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    289) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Tellurium Hexafluoride (Proposed). United States Environmental Protection Agency. Washington, DC. 2009i. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7e2a1&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    290) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Tert-Octyl Mercaptan (Proposed). United States Environmental Protection Agency. Washington, DC. 2008r. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648096e5c7&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    291) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Tetramethoxysilane (Proposed). United States Environmental Protection Agency. Washington, DC. 2006j. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d632&disposition=attachment&contentType=pdf. As accessed 2010-08-17.
    292) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Trimethoxysilane (Proposed). United States Environmental Protection Agency. Washington, DC. 2006i. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d632&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    293) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Trimethyl Phosphite (Proposed). United States Environmental Protection Agency. Washington, DC. 2009j. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7d608&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    294) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Trimethylacetyl Chloride (Proposed). United States Environmental Protection Agency. Washington, DC. 2008t. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648096e5cc&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    295) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Zinc Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005e. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    296) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for n-Butyl Isocyanate (Proposed). United States Environmental Protection Agency. Washington, DC. 2008m. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064808f9591&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    297) National Heart,Lung,and Blood Institute: Expert panel report 3: guidelines for the diagnosis and management of asthma. National Heart,Lung,and Blood Institute. Bethesda, MD. 2007. Available from URL: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf.
    298) National Institute for Occupational Safety and Health: NIOSH Pocket Guide to Chemical Hazards, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Cincinnati, OH, 2007.
    299) National Research Council : Acute exposure guideline levels for selected airborne chemicals, 5, National Academies Press, Washington, DC, 2007.
    300) National Research Council: Acute exposure guideline levels for selected airborne chemicals, 6, National Academies Press, Washington, DC, 2008.
    301) National Research Council: Acute exposure guideline levels for selected airborne chemicals, 7, National Academies Press, Washington, DC, 2009.
    302) National Research Council: Acute exposure guideline levels for selected airborne chemicals, 8, National Academies Press, Washington, DC, 2010.
    303) Neese Industries, Inc.: Fabric Properties Rating Chart. Neese Industries, Inc.. Gonzales, LA. 2003. Available from URL: http://www.neeseind.com/new/TechGroup.asp?Group=Fabric+Properties&Family=Technical. As accessed 4/15/2003.
    304) Newton TJ, Allran JW, O'Donnell JA, et al: Effects of ammonia on juvenile unionid mussels (Lampsilis cardium) in laboratory sediment toxicity tests. Environ Toxicol Chem 2003; 22/11:2554-2560.
    305) North: Chemical Resistance Comparison Chart - Protective Footwear . North Safety. Cranston, RI. 2002. Available from URL: http://www.linkpath.com/index2gisufrm.php?t=N-USA1. As accessed April 30, 2004.
    306) North: eZ Guide Interactive Software. North Safety. Cranston, RI. 2002a. Available from URL: http://www.northsafety.com/feature1.htm. As accessed 8/31/2002.
    307) Nuutinen M, Uhari M, & Karvali T: Consequences of caustic ingestions in children. Acta Paediatr 1994; 83:1200-1205.
    308) O'Kane GJ: Inhalation of ammonia vapour. Anaesthesia 1983; 38:1208-1213.
    309) OHM/TADS: Oil and Hazardous Materials Technical Assistance Data System. US Environmental Protection Agency. Washington, D.C. (Internet Version). Edition expires 2005; provided by Truven Health Analytics Inc., Greenwood Village, CO.
    310) OSHA : Hazard Information Bulletin: Accidental Release of Anhydrous Ammonia at Storage/Dispensing Facilities and Elevators. Occupational Safety and Health Administration. Washington, D.C. 1999. Available from URL: http://www.osha.gov/dts/hib/hib_data/hib19940228.html.
    311) OSHA: Ammonia Refrigeration: Emergency Response. Department of Labor: Occupational Safety and Health Administration. Washington, DC. 2004. Available from URL: http://www.osha.gov/SLTC/etools/ammonia_refrigeration/. As accessed Oct 5, 2005.
    312) Oakes DD, Sherck JP, & Mark JBD: Lye ingestion. J Thorac Cardiovasc Surg 1982; 83:194-204.
    313) Ortiz-Pujols S, Jones SW, Short KA, et al: Management and sequelae of a 41-year-old jehovah's witness with severe anhydrous ammonia inhalation injury. J Burn Care Res 2014; 35(3):e180-e183.
    314) Osweiler GD, Carson TL, & Buck WB: Clinical and Diagnostic Veterinary Toxicology, 3rd ed, Kendall/Hunt Publishing Co, Dubuque, IA, 1985.
    315) Paley RK, Twitchen ID, & Eddy FB: Ammonia, Na+, K+ and Cl- levels in rainbow trout yolk-sac fry in response to external ammonia. J Exp Biol 1993; 180:273-284.
    316) Pearson J & Stewart GR: The deposition of atmospheric ammonia and its effects on plants. New Phytol 1993; 125:283-305.
    317) Pelclova D & Navratil T: Do corticosteroids prevent oesophageal stricture after corrosive ingestion?. Toxicol Rev 2005; 24(2):125-129.
    318) Playtex: Fits Tough Jobs Like a Glove, Playtex, Westport, CT, 1995.
    319) Pontoppidan H, Geffin B, & Lowenstein E: Acute respiratory failure in the adult: Part I. N Engl J Med 1972; 287:690-698.
    320) Prenter J, MacNeil C, Dick JT, et al: Lethal and sublethal toxicity of ammonia to native, invasive, and parasitised freshwater amphipods. Water Res 2004; 38(12):2847-2850.
    321) Previtera C, Giusti F, & Gugliemi M: Predictive value of visible lesions (cheeks, lips, oropharynx) in suspected caustic ingestion: may endoscopy reasonably be omitted in completely negative pediatric patients?. Pediatr Emerg Care 1990; 6:176-178.
    322) Price SK, Hughes JE, & Morrison SC: Fatal ammonia inhalation. S Afr Med J 1983; 64:952-955.
    323) Proctor NH, Hughes JP, & Fischman ML: Chemical Hazards of the Workplace, 2nd ed, JB Lippincott Co, Philadelphia, PA, 1988.
    324) Prokopeva AS & Yushkov GG: Gig Tr Prof Zabol 1975; 9:54-55.
    325) Pushkina IK et al: Vopr Gig Tr Nov Technol Protsessami Mashinostroit Khim Prom-Sti. Mater Mosk Nauchn Konf, 1982.
    326) RTECS : Registry of Toxic Effects of Chemical Substances. National Institute for Occupational Safety and Health. Cincinnati, OH (Internet Version). Edition expires 2001; provided by Truven Health Analytics Inc., Greenwood Village, CO.
    327) RTECS: Registry of Toxic Effects of Chemical Substances.. National Institute for Occupational Safety and Health. Cincinnati, OH (Internet Version). Edition expires 2005; provided by Truven Health Analytics Inc., Greenwood Village, CO.
    328) Rao RB & Hoffman RS: Caustics and Batteries, in Goldfrank LR, Flomenbaum NE, Lewin NA et al (eds): Goldfrank's Toxicologic Emergencies, 7th ed, McGraw-Hill, New York, NY, 2002.
    329) Reisz GR & Gammon RS: Toxic pneumonitis from mixing household cleaners. Chest 1986; 89:49-52.
    330) Reyes HM, Lin CY, & Schluhk FF: Experimental treatment of corrosive esophageal burns. J Pediatr Surg 1974; 9:317-327.
    331) River City: Protective Wear Product Literature, River City, Memphis, TN, 1995.
    332) Robinson NE: Current Veterinary Therapy in Equine Medicine, 2, Saunders, Philadelphia, PA, 1987.
    333) Roesch RP, Stoelting RK, & Lingeman JE: Ammonia toxicity resulting from glycine absorption during a transurethral resection of the prostate. Anesthesiology 1983; 58:577-579.
    334) Rosenberg N, Kunderman PJ, & Vroman L: Prevention of experimental esophageal stricture by cortisone II. Arch Surg 1953; 66:593-598.
    335) Rumack BH & Burrington JD: Caustic ingestions: a rational look at diluents. Clin Toxicol 1977; 11:27-34.
    336) Rumack BH & Burrington JD: Caustic ingestions: a rational look at diluents. J Toxicol Clin Toxicol 1977a; 11:27-34.
    337) Saedi S, Nyhus LM, & Gabrys BF: Pharmacological prevention of esophageal stricture: an experimental study in the cat. Am Surg 1973a; 39:465-469.
    338) Saedi S, Nyhust LM, & Gabrys BF: Pharmacological prevention of esophageal stricture: an experimental study in the cat. Am Surg 1973; 39:465-469.
    339) Safety 4: North Safety Products: Chemical Protection Guide. North Safety. Cranston, RI. 2002. Available from URL: http://www.safety4.com/guide/set_guide.htm. As accessed 8/14/2002.
    340) Sax NI & Lewis RJ: Dangerous Properties of Industrial Materials, 7th ed, Van Nostrand Reinhold Co, New York, NY, 1989.
    341) Schild JA: Caustic ingestion in adult patients. Laryngoscope 1985; 95:1199-1201.
    342) Schjoerring JK, Kyllingsbaek A, & Mortensen JV: Field investigations of ammonia exchange between barley plants and the atmosphere. 1. concentration profiles and flux densities of ammonia. Plant Cell Environ 1993; 16:161-167.
    343) Schlienger JL: Diabetologia 1975; 11:439-443.
    344) Seiler N: Is ammonia a pathogenetic factor in Alzheimer's disease. Neurochem Res 1993; 18:235-245.
    345) Servus: Norcross Safety Products, Servus Rubber, Servus, Rock Island, IL, 1995.
    346) Shahandeh H, Cabrera ML, & Sumner ME: Ammonia volatilization from urea, ammonium sulfate and Nutrasweet sludge in bare and straw-covered soils. Commun Soil Sci Plant Anal 1992; 23:775-786.
    347) Shepard RL, Kraus SE, & Babayan RK: The role of ammonia toxicity in the post transurethral prostatectomy syndrome. Br J Urol 1987; 60:349-351.
    348) Shiba S, Hirata Y, & Zannetti P: Effect of ambient ammonia on acid rain formation caused by sulphur dioxide. Computer Techniques in Environmental Studies 1994; 1:57-66.
    349) Shiomoto A & Matsumura S: Diel periodicity in dark uptake of ammonium by natural populations of marine phytoplankton. J Plankton Res 1993; 15:1333-1339.
    350) Sittig M: Handbook of Toxic and Hazardous Chemicals and Carcinogens, 2nd ed, Noyes Publications, Park Ridge, NJ, 1985.
    351) Sjoblom E, Hojer J, & Kulling PEJ: A placebo-controlled experimental study of steroid inhalation therapy in ammonia-induced lung injury. Clin Toxicol 1999; 37:59-67.
    352) Smirnova NA & Granik MP: Gig Tr Prof Zabol 1971; 15:16-18.
    353) Smith BP: Large Animal Internal Medicine, The CV Mosby Company, Philadelphia, PA, 1990.
    354) Sorokina SF: Gig Tr Prof Zabol 1981; 9:31-34.
    355) Spingarn NE & Garvie CT: J Agric Food Chem 1979; 27:1319-1321.
    356) Spychajfabisjak J & Janowiak I: Loss of ammonia from soil by volatilization. Eurasian Soil Sci 1992; 24:88-95.
    357) Standard Safety Equipment: Product Literature, Standard Safety Equipment, McHenry, IL, 1995.
    358) Stolbach A & Hoffman RS: Respiratory Principles. In: Nelson LS, Hoffman RS, Lewin NA, et al, eds. Goldfrank's Toxicologic Emergencies, 9th ed. McGraw Hill Medical, New York, NY, 2011.
    359) Sugawa C & Lucas CE: Caustic injury of the upper gastrointestinal tract in adults: a clinical and endoscopic study. Surgery 1989; 106:802-807.
    360) Symbas PN, Vlasis SE, & Hatcher CR Jr: Esophagitis secondary to ingestion of caustic material. Ann Thorac Surg 1983; 36:73-77.
    361) Talbot P & Delanoue J: Tertiary treatment of wastewater with phormidium bohneri (Schmidle) under various light and temperature conditions. Water Res 1993; 27:153-159.
    362) Taplin GV, Chopra S, & Yanda RL: Radionuclidic lung-imaging in the assessment of injury due to ammonia. Chest 1976; 69:582-586.
    363) Targowski SP: Infect Imun 1984; 43:289-293.
    364) Tepper A, Comstock G, & Levine M: A longitudinal study of pulmonary function in fire fighters. Am J Ind Med 1991; 20:307-316.
    365) Tidy G & Cape JN: Ammonia concentrations in houses and public buildings. Atmos Environ Pt A-Gen Top 1993; 27:2235-2237.
    366) Tietema A & Verstraten JM: Nitrogen cycling in an acid forest ecosystem in the Netherlands under increased atmospheric nitrogen input - the nitrogen budget and the effect of nitrogen transformations on the proton budget. Biogeochem 1991; 15:21-46.
    367) Tingley: Chemical Degradation for Footwear and Clothing. Tingley. South Plainfield, NJ. 2002. Available from URL: http://www.tingleyrubber.com/tingley/Guide_ChemDeg.pdf. As accessed 10/16/2002.
    368) Treem WR, Long WR, & Friedman D: Successful management of an acquired gastric outlet obstruction with endoscopy guided balloon dilatation. J Pediatr Gastroenterol Nutr 1987; 6:992-996.
    369) Trelleborg-Viking, Inc.: Chemical and Biological Tests (database). Trelleborg-Viking, Inc.. Portsmouth, NH. 2002. Available from URL: http://www.trelleborg.com/protective/. As accessed 10/18/2002.
    370) Trelleborg-Viking, Inc.: Trellchem Chemical Protective Suits, Interactive manual & Chemical Database. Trelleborg-Viking, Inc.. Portsmouth, NH. 2001.
    371) Trifel NG: Tr Azerb Nauchno-Issled Inst Gig Tr Prof Azbol 1973; 8:129-132.
    372) U.S. Department of Energy, Office of Emergency Management: Protective Action Criteria (PAC) with AEGLs, ERPGs, & TEELs: Rev. 26 for chemicals of concern. U.S. Department of Energy, Office of Emergency Management. Washington, DC. 2010. Available from URL: http://www.hss.doe.gov/HealthSafety/WSHP/Chem_Safety/teel.html. As accessed 2011-06-27.
    373) U.S. Department of Health and Human Services, Public Health Service, National Toxicology Project : 11th Report on Carcinogens. U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program. Washington, DC. 2005. Available from URL: http://ntp.niehs.nih.gov/INDEXA5E1.HTM?objectid=32BA9724-F1F6-975E-7FCE50709CB4C932. As accessed 2011-06-27.
    374) U.S. Environmental Protection Agency: Discarded commercial chemical products, off-specification species, container residues, and spill residues thereof. Environmental Protection Agency's (EPA) Resource Conservation and Recovery Act (RCRA); List of hazardous substances and reportable quantities 2010b; 40CFR(261.33, e-f):77-.
    375) U.S. Environmental Protection Agency: Integrated Risk Information System (IRIS). U.S. Environmental Protection Agency. Washington, DC. 2011. Available from URL: http://cfpub.epa.gov/ncea/iris/index.cfm?fuseaction=iris.showSubstanceList&list_type=date. As accessed 2011-06-21.
    376) U.S. Environmental Protection Agency: List of Radionuclides. U.S. Environmental Protection Agency. Washington, DC. 2010a. Available from URL: http://www.gpo.gov/fdsys/pkg/CFR-2010-title40-vol27/pdf/CFR-2010-title40-vol27-sec302-4.pdf. As accessed 2011-06-17.
    377) U.S. Environmental Protection Agency: List of hazardous substances and reportable quantities. U.S. Environmental Protection Agency. Washington, DC. 2010. Available from URL: http://www.gpo.gov/fdsys/pkg/CFR-2010-title40-vol27/pdf/CFR-2010-title40-vol27-sec302-4.pdf. As accessed 2011-06-17.
    378) U.S. Environmental Protection Agency: The list of extremely hazardous substances and their threshold planning quantities (CAS Number Order). U.S. Environmental Protection Agency. Washington, DC. 2010c. Available from URL: http://www.gpo.gov/fdsys/pkg/CFR-2010-title40-vol27/pdf/CFR-2010-title40-vol27-part355.pdf. As accessed 2011-06-17.
    379) U.S. Occupational Safety and Health Administration: Part 1910 - Occupational safety and health standards (continued) Occupational Safety, and Health Administration's (OSHA) list of highly hazardous chemicals, toxics and reactives. Subpart Z - toxic and hazardous substances. CFR 2010 2010; Vol6(SEC1910):7-.
    380) U.S. Occupational Safety, and Health Administration (OSHA): Process safety management of highly hazardous chemicals. 29 CFR 2010 2010; 29(1910.119):348-.
    381) United States Environmental Protection Agency Office of Pollution Prevention and Toxics: Acute Exposure Guideline Levels (AEGLs) for Vinyl Acetate (Proposed). United States Environmental Protection Agency. Washington, DC. 2006. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d6af&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    382) Vale JA: Position Statement: gastric lavage. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 1997; 35:711-719.
    383) Vergauwen p, Moulin D, & Buts JP: Caustic burns of the upper digestive and respiratory tracts. Eur J Pediatr 1991; 150:700-703.
    384) Verschueren K: Handbook of Environmental Data on Organic Chemicals. 4th ed. CD-ROM version. Wiley-Interscience. Hoboken, NJ. 2001.
    385) Visek WJ: J Dairy Sci 1984; 67:481-498.
    386) Visek WJ: J Nutr 1985; 115:532-541.
    387) Wafar MVM, Wafar S, & Kumar RR: Nitrogen uptake kinetics of freshly isolated zooxanthellae. Indian J Mar Sci 1993; 22:83-88.
    388) Wallace DE: Consequence of exposure to aromatic ammonia solution in 15 patients (Abstract). Vet Human Toxicol 1989; 31:339.
    389) Wason S, Stephan M, & Breide C: Ingestion of aromatic ammonia 'smelling salts' capsules (Letter). Am J Dis Child 1990; 144:139-140.
    390) Weckhuysen B, Vriens L, & Verachtert H: Biotreatment of ammonia- and butanal-containing waste gases. Appl Microbiol Biotechnol 1994; 42:147-152.
    391) Welch GW, Lull RJ, & Petroff PA: The use of steroids in inhalation injury. Surg Gynecol Obstet 1977; 145:539-544.
    392) Wells Lamont Industrial: Chemical Resistant Glove Application Chart. Wells Lamont Industrial. Morton Grove, IL. 2002. Available from URL: http://www.wellslamontindustry.com. As accessed 10/31/2002.
    393) Wijburg FA, Beukers MM, & Heymans HS: Nasogastric intubation as sole treatment of caustic esophageal lesions. Ann Otol Rhinol Laryngol 1985; 94:337-341.
    394) Wijburg FA, Heymans HS, & Urbanus NA: Caustic esophageal lesions in childhood: prevention of stricture formation. J Pediatr Surg 1989; 24(2):171-173.
    395) Willson DF, Truwit JD, Conaway MR, et al: The adult calfactant in acute respiratory distress syndrome (CARDS) trial. Chest 2015; 148(2):356-364.
    396) Wilson DF, Thomas NJ, Markovitz BP, et al: Effect of exogenous surfactant (calfactant) in pediatric acute lung injury. A randomized controlled trial. JAMA 2005; 293:470-476.
    397) Wollenweber B & Raven JA: Nitrogen acquisition from atmospheric NH3 by Lolium perenne - utilization of NH3 and implications for acid-base balance. Bot Acta 1993; 106:42-51.
    398) Workrite: Chemical Splash Protection Garments, Technical Data and Application Guide, W.L. Gore Material Chemical Resistance Guide, Workrite, Oxnard, CA, 1997.
    399) Wu MH & Lai WW: Surgical management of extensive corrosive injuries of the alimentary tract. Surg Gynecol Obstetr 1993; 177:12-16.
    400) Yang GY, Tominack RL, & Deng JF: An industrial mass ammonia exposure (Abstract). Vet Human Toxicol 1987; 29:476.
    401) Yarington CT & Heatly CA: Steroids, antibiotics, and early esophagoscopy in caustic esophageal trauma. N Y State J Med 1963; 63:2960-2963.
    402) Zargar SA, Kochhar R, & Mehta S: The role of fiberoptic endoscopy in the management of corrosive ingestion and modified endoscopic classification of burns. Gastrointest Endosc 1991; 37:165-169.
    403) Zargar SA, Kochhar R, & Nagi B: Ingestion of corrosive acids: spectrum of injury to upper gastrointestinal tract and natural history. Gastroenterology 1989; 97:702-707.
    404) Ziarnik M, Otto W, & Sieger T: Ammonia contamination in a milk processing plant -- Wisconsin. MMWR 1986; 35:274-275.